{
"id":"mk19_b_gm_s4",
"subspecialtyId":"gm2",
"title":"Perioperative Medicine",
"jsonContent":{
"type":"section",
"id":"mk19_b_gm_s4",
"title":{
"__html":"Perioperative Medicine"
},
"titleNode":{
"type":"section-title",
"hlId":"5e12df",
"children":[
"Perioperative Medicine"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s4_1",
"title":{
"__html":"General Responsibilities"
},
"titleNode":{
"type":"section-title",
"hlId":"9cc85e",
"children":[
"General Responsibilities"
]
},
"children":[
{
"type":"p",
"hlId":"c48765",
"children":[
"Perioperative medicine encompasses risk assessment and optimization of comorbidities before surgery, intraoperative management, and postoperative care. The internist's role is to determine operative risk; communicate this information to patients, surgeons, and anesthesiologists; and recommend strategies to mitigate this risk. Decisions regarding the modality of surgical approach and anesthesia are best deferred to the anesthesiologist and surgeon. Commonly, hospitalists are also involved in the postoperative management of surgical patients."
]
},
{
"type":"p",
"hlId":"e6775e",
"children":[
"Internists can also assist with setting patient and family expectations in the perioperative period and ensuring that expected outcomes align with their goals."
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_1_1",
"title":{
"__html":"Preoperative Laboratory Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"90d281",
"children":[
"Preoperative Laboratory Testing"
]
},
"children":[
{
"type":"p",
"hlId":"0ca728",
"children":[
"All preoperative laboratory testing should be tailored on the basis of the nature of surgery, known comorbidities, and findings from the history or physical examination ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t21",
"wrapId":"1",
"children":[
"Table 21"
]
}
]
},
")"
]
},
". Routine laboratory panels are not recommended because they rarely guide management. For patients undergoing ambulatory or low-risk surgery (cataract, hernia repair), all preoperative testing is discouraged because there is minimal evidence of its usefulness."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_b_gm_t21"
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_1_2",
"title":{
"__html":"Perioperative Medication Management"
},
"titleNode":{
"type":"section-title",
"hlId":"ae33ab",
"children":[
"Perioperative Medication Management"
]
},
"children":[
{
"type":"p",
"hlId":"a833b2",
"children":[
"Perioperative medication management begins with eliciting a comprehensive medication history, including herbal preparations, supplements, and over-the-counter medications. Medication reconciliation should be performed to rectify any discrepancies within the medical record and prevent medication errors."
]
},
{
"type":"p",
"hlId":"a33d20",
"children":[
"High-quality evidence to guide perioperative medication management is lacking. Recommendations are largely derived from theoretical drug interactions and expert consensus. Although most medications are tolerated throughout the perioperative period and can be continued, there are some important exceptions. ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t22",
"wrapId":"2",
"children":[
"Table 22"
]
}
]
},
" provides recommendations for medications with potential surgery-related risk. Patients, surgeons, and inpatient providers should be given clear instructions on which medications to withhold preoperatively and guidance for when to safely resume. For antithrombotic management, collaboration with surgery, cardiology, anesthesiology, neurology, and/or anticoagulation services is critical."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_b_gm_t22"
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_1_3",
"title":{
"__html":"Postoperative Care"
},
"titleNode":{
"type":"section-title",
"hlId":"14483b",
"children":[
"Postoperative Care"
]
},
"children":[
{
"type":"p",
"hlId":"c11ee4",
"children":[
"Many strategies are used to reduce postoperative complications. In some settings, multimodal, evidence-based interventions have been standardized and bundled with preoperative and intraoperative protocols aimed at improving overall outcomes. These initiatives have been associated with reduced length of hospital stay, decreased complications, and improved functional recovery."
]
},
{
"type":"p",
"hlId":"7121ac",
"children":[
"Performing preoperative risk stratification in all patients can inform the degree of monitoring necessary for cardiac, pulmonary, renal, or neurologic dysfunction. Early detection of concerning changes in clinical status is the most effective way to prevent further decline. Laboratory monitoring should be driven by patient comorbidities, clinical status, and surgery type (for example, monitoring serum creatinine levels in patients with chronic kidney disease and large intraoperative fluid shifts)."
]
},
{
"type":"p",
"hlId":"f5fca2",
"children":[
"Postoperative urinary retention is a common postoperative complication. Risk factors include type of surgery (anorectal surgery, hernia repair, joint arthroplasty), longer surgery, type of anesthesia, use of opioids and anticholinergic agents, advanced age, constipation, history of urinary retention, and neurologic disease. Reversible causes of postoperative urinary retention, including medications such as opioids, should be addressed. In patients with benign prostatic hyperplasia, α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-blockers should be continued, whereas medications with associated anticholinergic effects, such as oxybutynin, should be withheld. Early removal of indwelling catheters and voiding trials are recommended, with ongoing close monitoring of urine output. In patients with low urine output after catheter removal, bladder ultrasonography should be performed to evaluate for urinary retention. When a voiding trial is unsuccessful (postvoid residual >300-400 mL), clean intermittent catheterization is indicated."
]
},
{
"type":"p",
"hlId":"33a330",
"children":[
"Postoperative ileus (POI) is relatively common after surgery. Abdominal distention and pain, nausea and vomiting, and inability to flatulate are all hallmarks of POI. Risk factors for POI include abdominal and pelvic surgery; open surgical technique; and presence of other postoperative complications, such as pneumonia. Treatment consists of minimizing the use of opioids, hydration, bowel rest, electrolyte repletion, postoperative ambulation, and use of chewing gum. Minimally invasive surgical approaches, multimodal analgesia techniques, prophylactic bowel regimens, and early ambulation may help to prevent POI. When POI is prolonged (lasting longer than 3-5 days), mechanical bowel obstruction should be considered."
]
},
{
"type":"p",
"hlId":"62da42",
"children":[
"Postoperative nausea and vomiting is a common event that results in significant patient distress. Risk factors include use of general anesthesia, opioids, female sex, and younger age. The internist plays an important role in ensuring adequate postoperative hydration, minimizing the use of opioids, and providing pharmacologic antiemetic therapy."
]
},
{
"type":"p",
"hlId":"39783a",
"children":[
"The occurrence of new postoperative atrial fibrillation, even if transient, is associated with increased short- and long-term mortality and incidence of stroke. When self-limited postoperative atrial fibrillation occurs, postoperative follow-up is indicated, including echocardiography and consideration of anticoagulation in at-risk patients."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"5bd8fe",
"hvc":true,
"children":[
"Preoperative routine laboratory panels are not recommended and can lead to unnecessary additional testing."
]
},
{
"type":"keypoint",
"hlId":"4ca46f",
"children":[
"In general, most medications are tolerated throughout the perioperative period."
]
},
{
"type":"keypoint",
"hlId":"84e0f5",
"hvc":true,
"children":[
"Early removal of indwelling catheters and voiding trials are recommended postoperatively, with ongoing close monitoring of urine output."
]
},
{
"type":"keypoint",
"hlId":"9d7dcf",
"children":[
"Treatment of postoperative ileus includes minimization of postoperative opioids, adequate hydration, bowel rest, electrolyte repletion, and postoperative ambulation."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_2",
"title":{
"__html":"Cardiovascular Perioperative Management"
},
"titleNode":{
"type":"section-title",
"hlId":"aad74f",
"children":[
"Cardiovascular Perioperative Management"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s4_2_1",
"title":{
"__html":"Cardiovascular Risk Assessment"
},
"titleNode":{
"type":"section-title",
"hlId":"f77292",
"children":[
"Cardiovascular Risk Assessment"
]
},
"children":[
{
"type":"p",
"hlId":"b0c845",
"children":[
"The preoperative cardiac evaluation is intended to assess patient risks for a major adverse cardiac event (MACE), such as ischemia, cardiac arrest, heart failure, and dysrhythmias, both during and after surgery. The widely accepted approach to risk stratification recommended by the American College of Cardiology (ACC)/American Heart Association (AHA) for patients undergoing noncardiac surgery is shown in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_b_gm_f02",
"wrapId":"3",
"children":[
"Figure 2"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_b_gm_f02"
]
},
{
"type":"p",
"hlId":"dd98e8",
"children":[
"Risk calculators can be used to determine the risk for perioperative MACE. The Revised Cardiac Risk Index (RCRI) ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t23",
"wrapId":"4",
"children":[
"Table 23"
]
}
]
},
")"
]
},
", the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator (",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://riskcalculator.facs.org/RiskCalculator",
"target":"_blank"
},
"children":[
"https://riskcalculator.facs.org/RiskCalculator"
]
},
"), and the Gupta Perioperative Risk for Myocardial Infarction or Cardiac Arrest (MICA) Calculator (",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.surgicalriskcalculator.com/miorcardiacarrest",
"target":"_blank"
},
"children":[
"www.surgicalriskcalculator.com/miorcardiacarrest"
]
},
") incorporate patient- and surgery-specific risk factors. Each calculator varies in terms of the population used for validation and overall performance ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t24",
"wrapId":"4",
"children":[
"Table 24"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_b_gm_t23",
"mk19_b_gm_t24"
]
},
{
"type":"p",
"hlId":"731192",
"children":[
"Patients with low calculated cardiovascular risk (<1% risk for perioperative MACE) may proceed to surgery, whereas patients with elevated risk (≥1% risk for perioperative MACE) should have functional capacity assessed. Metabolic equivalents (METs) are used to represent a patient's functional capacity based on the intensity of activity the patient is able to perform. According to the ACC/AHA guideline, if functional capacity exceeds 4 METs, the patient may proceed to surgery without further testing. The Duke Activity Status Index (DASI) score ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t25",
"wrapId":"5",
"children":[
"Table 25"
]
}
]
},
")"
]
},
" is a standardized and accurate means of estimating exercise capacity; data from the METS trial showed that clinician estimates of exercise capacity without use of a standardized tool do not correlate with actual patient performance on cardiopulmonary exercise testing nor with postoperative cardiac outcomes. Preoperative cardiac stress testing should be considered in patients at elevated risk for MACE with functional capacity objectively assessed to not be low risk, but only if the results will change perioperative management. An alternative approach from the Canadian Cardiovascular Society does not use preoperative cardiac stress testing and instead suggests assessing perioperative risk using patient age, presence of known cardiovascular disease, the RCRI, and B-type natriuretic peptide."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_b_gm_t25"
]
},
{
"type":"p",
"hlId":"d3c3bf",
"children":[
"Preoperative ECG is reasonable in patients with known cardiovascular disease undergoing moderate- to high-risk surgeries. Preoperative ECG may be considered for asymptomatic patients except those undergoing low-risk procedures. ECG rarely alters preoperative decision making but may provide a useful baseline to guide postoperative management in the event of complications."
]
},
{
"type":"p",
"hlId":"a045e0",
"children":[
"Echocardiography should not be routinely performed preoperatively. Specific indications for echocardiography include the presence of dyspnea of unknown origin, heart failure with worsening dyspnea or change in clinical status, known left ventricular dysfunction without echocardiographic assessment in the last year, and known or suspected moderate to severe valvular stenosis or regurgitation without echocardiographic assessment in the past year or with a change in clinical status."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_2_2",
"title":{
"__html":"Cardiovascular Risk Management"
},
"titleNode":{
"type":"section-title",
"hlId":"32efc3",
"children":[
"Cardiovascular Risk Management"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s4_2_2_1",
"title":{
"__html":"Coronary Artery Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"afb9af",
"children":[
"Coronary Artery Disease"
]
},
"children":[
{
"type":"p",
"hlId":"b59538",
"children":[
"Patients with coronary artery disease should not undergo routine coronary angiography or revascularization before surgery. These procedures should be reserved for patients with recognized indications based on clinical practice guidelines. It is recommended that elective surgery be delayed 14 days after balloon angioplasty, 30 days after bare metal stent implantation, and 6 months after drug-eluting stent placement. However, if the risk of surgical delay outweighs the risk for ischemia and stent thrombosis, surgery may be considered 90 days after drug-eluting placement. Patients with an acute coronary syndrome not managed with coronary intervention are still at elevated risk for postoperative MACE, and elective surgery should be delayed for at least 60 days after the event."
]
},
{
"type":"p",
"hlId":"62720e",
"children":[
"Patients taking β-blockers, statins, and most antihypertensive medications (with the possible exceptions of diuretics and ACE inhibitors) should continue these medications perioperatively unless prohibited by hypotension. In some circumstances, β-blocker or statin therapy is initiated preoperatively (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t22",
"wrapId":"6",
"children":[
"Table 22"
]
}
]
},
")"
]
},
". Postoperative β-blocker administration should be guided by clinical circumstances, but dose reduction is preferred to discontinuation if hypotension develops."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_b_gm_t22"
]
},
{
"type":"p",
"hlId":"b885d9",
"children":[
"The ACC/AHA perioperative evaluation and management guideline does not recommend routine measurement of postoperative troponin or ECG, but these studies should be obtained if signs or symptoms of myocardial ischemia develop. However, in many cases, postoperative myocardial ischemia is asymptomatic or presents atypically. The Canadian Cardiovascular Society recommends daily measurement of troponin levels for up to 3 days after surgery in patients at elevated risk for MACE, although the best means of managing patients with postoperative low-level troponin elevations is unclear."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_2_2_2",
"title":{
"__html":"Heart Failure"
},
"titleNode":{
"type":"section-title",
"hlId":"6ff5ed",
"children":[
"Heart Failure"
]
},
"children":[
{
"type":"p",
"hlId":"59322d",
"children":[
"Medical management of decompensated heart failure should be optimized before surgery (see ",
{
"type":"cross-reference",
"target":"mk19_b_cv_s4_4_3",
"children":[
"MKSAP 19 Cardiovascular Medicine"
]
},
")."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_2_2_3",
"title":{
"__html":"Cardiac Arrhythmias"
},
"titleNode":{
"type":"section-title",
"hlId":"ed70fa",
"children":[
"Cardiac Arrhythmias"
]
},
"children":[
{
"type":"p",
"hlId":"140fb2",
"children":[
"Risk management strategies for patients with a cardiac arrhythmia who are undergoing surgery include continuation of antiarrhythmic medications and, for some patients, continuous cardiac monitoring."
]
},
{
"type":"p",
"hlId":"21696a",
"children":[
"Patients with atrial fibrillation are at risk for rapid ventricular rate due to surgical stress, fluid shifts, and postoperative pain. Maintaining euvolemia, optimizing pain management, and continuing baseline rate control medications can reduce this risk."
]
},
{
"type":"p",
"hlId":"8058d8",
"children":[
"A cardiologist should be consulted in patients with a pacemaker or implantable cardioverter-defibrillator who are undergoing surgery to assure normal device function and obtain recommendations for perioperative management of the device. Patients in whom a device has been deactivated for surgery should undergo continuous cardiac monitoring until the device is reprogrammed."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_2_2_4",
"title":{
"__html":"Valvular Heart Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"959b4e",
"children":[
"Valvular Heart Disease"
]
},
"children":[
{
"type":"p",
"hlId":"987111",
"children":[
"The ACC/AHA guideline states that it is reasonable to perform elective noncardiac surgery in patients with severe asymptomatic aortic stenosis, mitral regurgitation, or aortic regurgitation with preserved left ventricular function. However, these patients are at higher risk for cardiovascular complications, necessitating awareness among surgical teams. Efforts to avoid large volume shifts and minimizing hypotension and tachycardia are critical. Valvular intervention should be performed before elective noncardiac surgery in patients who are candidates for valvular intervention owing to symptoms or severity of disease."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_2_2_5",
"title":{
"__html":"Pulmonary Hypertension"
},
"titleNode":{
"type":"section-title",
"hlId":"c0fd61",
"children":[
"Pulmonary Hypertension"
]
},
"children":[
{
"type":"p",
"hlId":"a979ff",
"children":[
"Patients with pulmonary hypertension undergoing noncardiac surgery have higher mortality and morbidity, including nonfatal myocardial ischemia, VTE, cardiogenic shock, and dysrhythmias. Preoperative evaluation by a pulmonary hypertension specialist is advised for patients with high-risk features, including group 1 pulmonary hypertension (pulmonary arterial hypertension), pulmonary artery systolic pressure greater than 70 mm Hg, moderate or severe right ventricular systolic dysfunction, and New York Heart Association functional class III or IV symptoms attributable to pulmonary hypertension. Postoperatively, maintaining preload, optimal pain control, and normal heart rate and blood pressure are important. Patients should be continued on pulmonary vascular targeted therapies, such as phosphodiesterase-5 inhibitors and prostacyclin analogues."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_2_2_6",
"title":{
"__html":"Hypertension"
},
"titleNode":{
"type":"section-title",
"hlId":"01da3e",
"children":[
"Hypertension"
]
},
"children":[
{
"type":"p",
"hlId":"b90180",
"children":[
"In patients with hypertension, urgent blood pressure lowering is not mandatory preoperatively unless there is evidence of end-organ dysfunction, in which case surgery should be delayed and blood pressure treated. Deferral of surgery may also be considered in patients with a systolic blood pressure of 180 mm Hg or higher or diastolic blood pressure of 110 mm Hg or higher. Moderate preoperative hypertension has not been linked to adverse perioperative outcomes, although evidence is lacking regarding a specific blood pressure threshold. The perioperative use of specific antihypertensive agents is outlined in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t22",
"wrapId":"7",
"children":[
"Table 22"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_b_gm_t22"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"195e11",
"hvc":true,
"children":[
"Patients with low cardiovascular risk (<1% risk for perioperative major adverse cardiac event [MACE]) may proceed to surgery, whereas patients with elevated risk (≥1% risk for perioperative MACEs) should undergo objective assessment of functional capacity."
]
},
{
"type":"keypoint",
"hlId":"3a3e5d",
"hvc":true,
"children":[
"Preoperative ECG is reasonable in patients with known cardiovascular disease undergoing moderate- to high-risk surgeries and may be considered for other asymptomatic patients, except those undergoing low-risk procedures."
]
},
{
"type":"keypoint",
"hlId":"51efd5",
"hvc":true,
"children":[
"Patients with coronary artery disease should not undergo routine coronary angiography or revascularization before surgery exclusively to reduce perioperative events."
]
},
{
"type":"keypoint",
"hlId":"fdfcdc",
"children":[
"Patients with hypertension who are undergoing surgery do not require urgent blood pressure lowering preoperatively unless there is evidence of end-organ dysfunction."
]
}
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_3",
"title":{
"__html":"Pulmonary Perioperative Management"
},
"titleNode":{
"type":"section-title",
"hlId":"c69e48",
"children":[
"Pulmonary Perioperative Management"
]
},
"children":[
{
"type":"p",
"hlId":"5be82b",
"children":[
"Perioperative pulmonary complications include pneumonia, respiratory failure, and exacerbation of underlying lung disease. Pulmonary perioperative management involves pulmonary risk assessment, including screening for obstructive sleep apnea (OSA), assessment of underlying lung disease and treatment optimization, and use of perioperative risk-reduction strategies."
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_3_1",
"title":{
"__html":"Pulmonary Risk Assessment"
},
"titleNode":{
"type":"section-title",
"hlId":"e66c02",
"children":[
"Pulmonary Risk Assessment"
]
},
"children":[
{
"type":"p",
"hlId":"16a6d1",
"children":[
"Patients should be asked preoperatively about any recent signs or symptoms of acute respiratory illness or chronic lung disease exacerbation."
]
},
{
"type":"p",
"hlId":"61b91c",
"children":[
"Pulmonary risk factors can be categorized as patient-related factors or procedure-related factors ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t26",
"wrapId":"8",
"children":[
"Table 26"
]
}
]
},
")"
]
},
". Risk calculators that include many of the important risk factors and other predictors may help determine postoperative risk for respiratory failure, pneumonia, and overall pulmonary complications. The ARISCAT score has been externally validated and measures risk for a wide variety of perioperative pulmonary complications (",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.mdcalc.com/ariscat-score-postoperative-pulmonary-complications",
"target":"_blank"
},
"children":[
"www.mdcalc.com/ariscat-score-postoperative-pulmonary-complications"
]
},
"). To date, ARISCAT and other available risk calculators do not incorporate OSA but are useful in estimating general pulmonary risk."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_b_gm_t26"
]
},
{
"type":"p",
"hlId":"4dd56b",
"children":[
"All patients should be screened for OSA, which is associated with cardiac events, pulmonary complications, and ICU admissions. A commonly used screening tool for OSA is the STOP-BANG score ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t27",
"wrapId":"9",
"children":[
"Table 27"
]
}
]
},
")"
]
},
". Although there is a paucity of data supporting delay of surgery in patients at high risk for OSA, the Society of Anesthesia and Sleep Medicine recommends preoperative sleep medicine evaluation in patients screened as high risk for OSA who also have evidence of hypoventilation (CO",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" retention), severe or uncontrolled comorbidities, or resting hypoxemia not attributable to other cardiopulmonary causes."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_b_gm_t27"
]
},
{
"type":"p",
"hlId":"2b9c81",
"children":[
"Chest radiography is indicated only in patients with signs or symptoms of pulmonary illness or underlying cardiac or pulmonary disease with new or unstable symptoms. Spirometry is not useful for predicting risk and should not be routinely ordered for preoperative evaluation, including in patients with COPD. Furthermore, evidence does not support a spirometric threshold below which the risk of surgery is unacceptable. However, spirometry is warranted in patients undergoing lung resection to help predict postoperative lung function."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_3_2",
"title":{
"__html":"Perioperative Risk-Reduction Strategies"
},
"titleNode":{
"type":"section-title",
"hlId":"87f205",
"children":[
"Perioperative Risk-Reduction Strategies"
]
},
"children":[
{
"type":"p",
"hlId":"a3a3b1",
"children":[
"Risk for perioperative pulmonary complications can be mitigated with selected interventions, including oral hygiene, early mobilization, use of regional or neuraxial anesthesia and analgesia, prophylactic respiratory physiotherapy (sputum clearance techniques, deep breathing exercises, and inspiratory muscle training) and postoperative continuous positive pressure ventilation. Surgery should be postponed and appropriate treatment initiated if there is concern for exacerbation of underlying disease or respiratory illness. Smoking cessation reduces pulmonary risk and should be encouraged as far in advance of surgery as possible. Prescribed inhaled medications should be continued throughout the perioperative period. Perioperative management should also include goal-directed fluid management and consideration of lung-protective ventilation strategies."
]
},
{
"type":"p",
"hlId":"b16457",
"children":[
"In patients diagnosed with OSA, continuous positive airway pressure should be initiated preoperatively when possible. For patients with suspected OSA undergoing nonelective surgery, management includes postoperative monitoring with continuous pulse oximetry or capnography, nonsupine positioning, and limiting sedating medications. Patients with known OSA should bring their continuous positive airway pressure device to the hospital for use in the perioperative period."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"317408",
"hvc":true,
"children":[
"Preoperative chest radiography is indicated only in patients with signs or symptoms of pulmonary illness or in those with underlying cardiac or pulmonary disease and new or unstable symptoms."
]
},
{
"type":"keypoint",
"hlId":"744b74",
"hvc":true,
"children":[
"Spirometry should not be routinely performed preoperatively except in patients undergoing lung resection."
]
},
{
"type":"keypoint",
"hlId":"738e3d",
"children":[
"All patients undergoing surgery should be screened for obstructive sleep apnea, which is associated with adverse perioperative outcomes."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_4",
"title":{
"__html":"Hematologic Perioperative Management"
},
"titleNode":{
"type":"section-title",
"hlId":"b1b95a",
"children":[
"Hematologic Perioperative Management"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s4_4_1",
"title":{
"__html":"Venous Thromboembolism Prophylaxis"
},
"titleNode":{
"type":"section-title",
"hlId":"272743",
"children":[
"Venous Thromboembolism Prophylaxis"
]
},
"children":[
{
"type":"p",
"hlId":"8da3c6",
"children":[
"The American College of Chest Physicians (ACCP) and the American Society for Hematology (ASH) provide guidelines for VTE prophylaxis in both orthopedic and nonorthopedic surgery populations ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t28",
"wrapId":"10",
"children":[
"Table 28"
]
}
]
},
")"
]
},
". In patients undergoing general surgery or abdominal-pelvic surgery, the Caprini score can be used to estimate risk for postoperative thrombosis (",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.mdcalc.com/caprini-score-venous-thromboembolism-2005",
"target":"_blank"
},
"children":[
"www.mdcalc.com/caprini-score-venous-thromboembolism-2005"
]
},
")."
]
},
{
"type":"inline-wrap",
"wrapId":"10",
"contentIds":[
"mk19_b_gm_t28"
]
},
{
"type":"p",
"hlId":"7d431b",
"children":[
"Hip fracture surgery, total knee arthroplasty, and total hip arthroplasty pose a very high risk for VTE, and concomitant mechanical and pharmacologic VTE prophylaxis are recommended. Mechanical prophylaxis is provided with an intermittent pneumatic compression device for the duration of the hospital stay. For pharmacologic prophylaxis, direct oral anticoagulants (DOACs), aspirin, low-molecular-weight heparin, warfarin, or low-dose unfractionated heparin may be used in total joint arthroplasty, and low-molecular-weight heparin, low-dose unfractionated heparin, or fondaparinux may be used in hip fracture repair. The minimum recommended duration of pharmacologic VTE prophylaxis after these procedures is 10 to 14 days; however, provided that the bleeding risk is low, extended-duration postoperative prophylaxis (up to 35 days from the day of surgery) is preferred."
]
},
{
"type":"p",
"hlId":"91c283",
"children":[
"If bleeding risk is especially high, mechanical prophylaxis is recommended over no prophylaxis."
]
},
{
"type":"p",
"hlId":"f40233",
"children":[
"Both ACCP and ASH recommend against preoperative placement of inferior vena cava filters for VTE prophylaxis and routine surveillance for VTE with venous compression ultrasonography."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_4_2",
"title":{
"__html":"Perioperative Management of Anticoagulant Therapy"
},
"titleNode":{
"type":"section-title",
"hlId":"849864",
"children":[
"Perioperative Management of Anticoagulant Therapy"
]
},
"children":[
{
"type":"p",
"hlId":"da0a8e",
"children":[
"Anticoagulant therapy increases the risk for perioperative hemorrhage and should be withheld in most patients before major surgery. For minor surgery, such as cataracts, simple skin surgery, or simple dental extractions, anticoagulation may be continued. When necessary to discontinue, vitamin K antagonists should be withheld at least 5 days before surgery; most procedures can be safely performed with an INR less than 1.5. The duration for which DOACs are withheld before surgery depends on the bleeding risk of the procedure, kidney function, and medication half-life; in general, DOACs can be stopped 2 to 3 days preoperatively because of their shorter half-lives."
]
},
{
"type":"p",
"hlId":"9f5740",
"children":[
"Bridging anticoagulation is the administration of therapeutic doses of short-acting parenteral therapy, usually a heparin, when oral anticoagulant therapy is being withheld during the perioperative period. Newer guidelines recommend against bridging in most scenarios due to limited benefit and elevated bleeding risk. Bridging with a parenteral agent should only be considered in patients with a high thrombotic risk (atrial fibrillation with a high CHA",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"DS",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-VASc score, recent thromboembolic event [e.g., such as stroke or presence of a high-thrombotic-risk mechanical valve]). Bridging is not indicated with DOACs owing to the rapid onset and short half-life of these drugs."
]
},
{
"type":"p",
"hlId":"f68956",
"children":[
"Postprocedural management of anticoagulation should be guided by thrombotic and bleeding risk and collaboration with the surgical team. If bridging is required, therapeutic anticoagulation is typically delayed until 24 hours after procedures with low bleeding risk and 48 to 72 hours after surgery with higher bleeding risk. Owing to their delayed effect, the first dose of a vitamin K antagonist is typically administered 12 to 24 hours after surgery. Postoperative timing of DOAC reinstitution depends on postoperative kidney function, bleeding risk, and hemostasis. DOACs reach therapeutic levels in 1 to 3 hours and can typically be resumed 48 to 72 hours after major surgery."
]
},
{
"type":"p",
"hlId":"5f67d5",
"children":[
"Because of the risk for spinal epidural hematoma, anticoagulant use with concomitant neuraxial (spinal and epidural) anesthesia should be avoided."
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_4_2_1",
"title":{
"__html":"Atrial Fibrillation"
},
"titleNode":{
"type":"section-title",
"hlId":"5e6e34",
"children":[
"Atrial Fibrillation"
]
},
"children":[
{
"type":"p",
"hlId":"d4fa8f",
"children":[
"According to AHA/ACC/Heart Rhythm Society and ACCP guidelines, preoperative bridging is not recommended in patients with atrial fibrillation taking warfarin unless they have a mechanical valve. Decisions on bridging therapy should balance the risks of stroke and bleeding."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_4_2_2",
"title":{
"__html":"Prosthetic Heart Valves"
},
"titleNode":{
"type":"section-title",
"hlId":"d26dc8",
"children":[
"Prosthetic Heart Valves"
]
},
"children":[
{
"type":"p",
"hlId":"a86bcf",
"children":[
"In patients receiving warfarin anticoagulant therapy for a mechanical prosthetic heart valve, continuation of anticoagulation is recommended when the surgical procedure is minor. In patients undergoing surgery with a higher risk for bleeding, the 2017 ACC/AHA guideline on valvular heart disease suggests that bridging should be considered on an individualized basis in patients with a mechanical mitral valve; a mechanical aortic valve with thromboembolic risk factors (such as atrial fibrillation, previous stroke or transient ischemic attack, hypertension, diabetes mellitus, heart failure, or age ≥75 years); or an older-generation mechanical aortic valve. Bridging is not necessary in patients with a bileaflet mechanical aortic valve and no other risk factors for thrombosis. The ACCP provides similar recommendations for bridging anticoagulation in patients with prosthetic heart valves ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t29",
"wrapId":"11",
"children":[
"Table 29"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"11",
"contentIds":[
"mk19_b_gm_t29"
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_4_2_3",
"title":{
"__html":"Venous Thromboembolic Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"d1628c",
"children":[
"Venous Thromboembolic Disease"
]
},
"children":[
{
"type":"p",
"hlId":"24b0b2",
"children":[
"Recommendations for bridging anticoagulation in patients with a history of VTE, including those with thrombophilias, are listed in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t30",
"wrapId":"12",
"children":[
"Table 30"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"12",
"contentIds":[
"mk19_b_gm_t30"
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_4_3",
"title":{
"__html":"Perioperative Management of Antiplatelet Medications"
},
"titleNode":{
"type":"section-title",
"hlId":"020dc6",
"children":[
"Perioperative Management of Antiplatelet Medications"
]
},
"children":[
{
"type":"p",
"hlId":"0994df",
"children":[
"The perioperative management of dual antiplatelet therapy (DAPT), comprising aspirin plus a P2Y",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" inhibitor, in patients with coronary artery disease depends on the presence of a bare metal or drug-eluting coronary stent; time since stent placement; and, to some degree, the indication for DAPT (stable ischemic heart disease or acute coronary syndrome within the past year)."
]
},
{
"type":"p",
"hlId":"631515",
"children":[
"In patients with coronary stents, DAPT should be continued uninterrupted for at least 14 to 30 days after bare metal stent placement and 3 to 6 months after drug-eluting stent placement, whereas 12 months of DAPT is preferred following an acute coronary syndrome. Elective surgery should be postponed during these time frames if DAPT cannot be safely continued throughout the perioperative period. However, if the risk of surgical delay exceeds the risk for stent thrombosis, discontinuation of the P2Y",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" inhibitor can be considered after a minimum of 3 months in patients with a drug-eluting stent. Aspirin (preferably low dose) should be continued if at all possible, and DAPT should be restarted as soon as bleeding risk has sufficiently diminished."
]
},
{
"type":"p",
"hlId":"401a0e",
"children":[
"In most patients receiving long-term aspirin monotherapy for both primary and secondary prevention of cardiovascular events, aspirin should be discontinued at least 5 days before surgery and restarted postoperatively once bleeding risk has decreased. This recommendation is based on the POISE-2 trial, which showed that perioperative aspirin use resulted in increased bleeding without a decrease in cardiac events. However, a subgroup analysis of this trial showed greater benefit than harm to continuing perioperative aspirin in patients with prior percutaneous coronary intervention during any time frame."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_4_4",
"title":{
"__html":"Perioperative Management of Anemia, Coagulopathies, and Thrombocytopenia"
},
"titleNode":{
"type":"section-title",
"hlId":"3f345f",
"children":[
"Perioperative Management of Anemia, Coagulopathies, and Thrombocytopenia"
]
},
"children":[
{
"type":"p",
"hlId":"641904",
"children":[
"A careful preoperative bleeding history, including a family history, should be obtained from all patients before surgery to evaluate for underlying bleeding disorders and anemia. Laboratory testing should be reserved for patients with a suggestive history. Patients with known factor deficiencies, platelet function defects, and other coagulopathies should have a preoperative consultation with a hematologist."
]
},
{
"type":"p",
"hlId":"862776",
"children":[
"In orthopedic and cardiac surgery patients and those with a history of preexisting cardiovascular disease, the American Association of Blood Banks recommends a restrictive transfusion threshold (hemoglobin level of 8 g/dL [80 g/L]) because studies indicate equivalent or improved patient outcomes compared with higher transfusion thresholds. In all other hospitalized hemodynamically stable patients, a transfusion threshold of 7 g/dL (70 g/L) is recommended."
]
},
{
"type":"p",
"hlId":"089b8f",
"children":[
"The American Association of Blood Banks recommends a platelet transfusion threshold of 50,000 cells/µL (50 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
" cells/L) for patients undergoing major non-neurologic surgery or lumbar puncture. Postoperative thrombocytopenia can result from blood loss, consumption, or drugs (especially heparin-induced thrombocytopenia). For a discussion of heparin-induced thrombocytopenia, see ",
{
"type":"cross-reference",
"target":"mk19_b_hm_s6_3_2_3",
"children":[
"MKSAP 19 Hematology"
]
},
"."
]
},
{
"type":"p",
"hlId":"b560b6",
"children":[
"Preoperative anemia and postoperative red cell transfusion are associated with increased complications and mortality. When anemia is identified before elective surgery, efforts should be made to correct reversible causes and optimize red blood cell mass."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"9a39db",
"children":[
"Hip fracture surgery, total knee arthroplasty, and total hip arthroplasty pose a very high risk for VTE, and both mechanical and pharmacologic VTE prophylaxis are recommended."
]
},
{
"type":"keypoint",
"hlId":"cf790d",
"children":[
"The minimum recommended duration of pharmacologic venous thromboembolism prophylaxis in patients undergoing orthopedic surgery is 10 to 14 days; however, in patients without increased bleeding risk, extended-duration postoperative prophylaxis (up to 35 days) is preferred."
]
},
{
"type":"keypoint",
"hlId":"92012b",
"children":[
"In patients treated with percutaneous coronary intervention who are undergoing elective noncardiac surgery, dual antiplatelet therapy should be continued uninterrupted for 14 to 30 days after bare metal stent placement and optimally 3 to 6 months after drug-eluting stent placement."
]
},
{
"type":"keypoint",
"hlId":"201e1c",
"hvc":true,
"children":[
"In orthopedic and cardiac surgery patients and those with a history of coronary artery disease, the American Association of Blood Banks recommends a restrictive transfusion threshold (hemoglobin level of 8 g/dL [80 g/L]); otherwise, a transfusion threshold of 7 g/dL (70 g/L) is recommended."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_5",
"title":{
"__html":"Perioperative Management of Endocrine Diseases"
},
"titleNode":{
"type":"section-title",
"hlId":"a246d7",
"children":[
"Perioperative Management of Endocrine Diseases"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s4_5_1",
"title":{
"__html":"Diabetes Mellitus"
},
"titleNode":{
"type":"section-title",
"hlId":"983bb7",
"children":[
"Diabetes Mellitus"
]
},
"children":[
{
"type":"p",
"hlId":"2e0d41",
"children":[
"Evidence demonstrates that patients with perioperative hyperglycemia are at increased risk for postoperative complications, including infections, cardiovascular events, and mortality. Patients at risk for diabetes should be evaluated for diabetes before elective surgery. In patients with known diabetes, it is reasonable to obtain hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
},
" within 3 months of surgery. Efforts should be made to optimize glycemic control before major elective surgery; however, it is undecided whether delaying surgery to do so improves outcomes."
]
},
{
"type":"p",
"hlId":"b9906f",
"children":[
"Oral and injectable noninsulin medications should be withheld the morning of major surgery, replaced with insulin during hospitalization, and resumed at hospital discharge when oral intake and kidney function have normalized. Sodium-glucose cotransporter-2 inhibitors should be withheld 3 to 4 days owing to the risk for euglycemic ketoacidosis. For patients on insulin regimens, basal insulin should be continued perioperatively. While fasting for surgery, patients should receive 50% of their usual intermediate-acting insulin dose, or 60% to 80% of their long-acting analogue dose or pump basal insulin rate. In patients with type I diabetes who are not prone to hypoglycemia, the normal basal insulin dose may be continued. The usual dose of short- and rapid-acting insulins can be administered before the day of surgery but should be held on the day of surgery unless required to correct hyperglycemia."
]
},
{
"type":"p",
"hlId":"060e53",
"children":[
"Postoperatively, if the patient is eating, the ideal insulin regimen is a basal-bolus regimen, with nutritional coverage and correction boluses for pre-meal hyperglycemia. For a discussion of the management of hyperglycemia in the hospital setting, see ",
{
"type":"cross-reference",
"target":"mk19_b_en_s1_3",
"children":[
"MKSAP 19 Endocrinology and Metabolism"
]
},
"."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_5_2",
"title":{
"__html":"Thyroid Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"7d71ae",
"children":[
"Thyroid Disease"
]
},
"children":[
{
"type":"p",
"hlId":"07e9da",
"children":[
"Preoperative screening for thyroid disease is not recommended in the absence of symptoms. In patients with symptoms suggestive of thyroid disease or in those with a recent change in levothyroxine dosage, it is reasonable to obtain a preoperative thyroid-stimulating hormone level."
]
},
{
"type":"p",
"hlId":"591930",
"children":[
"In patients with hypothyroidism treated with levothyroxine, therapy should continue uninterrupted. Patients with untreated, asymptomatic mild hypothyroidism may proceed to surgery because there is no apparent increase in perioperative mortality and morbidity. However, severe hypothyroidism can lead to perioperative myxedema coma, arrhythmias, hypotension, and other complications. Elective surgery in these patients should be postponed."
]
},
{
"type":"p",
"hlId":"0f7526",
"children":[
"In patients with well-controlled hyperthyroidism, therapy should be continued. Uncontrolled hyperthyroidism increases risk for thyroid storm perioperatively; thus, surgery should be deferred until thyroid disease can be controlled."
]
},
{
"type":"p",
"hlId":"c060a1",
"children":[
"Consultation with an endocrinologist is advised if emergent surgery is required in patients with severe thyroid disease."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_5_3",
"title":{
"__html":"Adrenal Insufficiency"
},
"titleNode":{
"type":"section-title",
"hlId":"a5180d",
"children":[
"Adrenal Insufficiency"
]
},
"children":[
{
"type":"p",
"hlId":"72cf06",
"children":[
"High-quality evidence to guide the use of perioperative supplemental glucocorticoid dosing, known as stress dosing, is lacking. Increasingly, stress dosing is only administered in the perioperative setting in the case of major surgery when there is known primary or secondary adrenal insufficiency or if a patient is at high risk for hypothalamic-pituitary-adrenal axis (HPAA) suppression. Despite the lack of evidence, the anesthesiology literature recommends an aggressive approach. Guidance for perioperative management of patients at risk for adrenal insufficiency is provided in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t31",
"wrapId":"13",
"children":[
"Table 31"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"13",
"contentIds":[
"mk19_b_gm_t31"
]
},
{
"type":"p",
"hlId":"6e1a3e",
"children":[
"The exact time course for recovery from HPAA suppression from previous glucocorticoid use varies between individuals. When perioperative stress dosing is indicated owing to suspected HPAA suppression, glucocorticoid dosing recommendations are tailored to the stress of the planned procedure. For minor surgical procedures using only local anesthesia, patients with primary adrenal insufficiency should take twice their usual dose of glucocorticoids on the day of surgery and for 1 to 2 days after; other patients at risk for adrenal insufficiency can take their usual daily glucocorticoids dose on the morning of the procedure. Recommendations for non-minor surgery vary. For non-minor surgical procedures, the Association of Anaesthetists recommends giving 100 mg of intravenous (IV) hydrocortisone with induction of anesthesia followed by continuous infusion of 200 mg/d of IV hydrocortisone until the patient can resume oral glucocorticoids. Once oral glucocorticoids are resumed, twice the usual daily dose should be administered for 48 hours after surgery. Counter to these guidelines, many experts suggest replacing the continuous infusion with intermittent dosing of 50 mg of hydrocortisone every 6 hours until oral intake is resumed. In addition, using lower doses with induction for minor- or intermediate-stress surgeries and administering a similar dose of postoperative IV hydrocortisone may be an acceptable strategy."
]
},
{
"type":"p",
"hlId":"2a4b1b",
"children":[
"In all situations, the patient's individual characteristics (for example, risk for hyperglycemia) and the surgical stress should be carefully considered. Furthermore, if preoperative stress dosing is not used, clinicians should assure that patients take their usual glucocorticoid dose on the morning of the procedure and remain vigilant for signs and symptoms of adrenal insufficiency postoperatively."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"57734a",
"children":[
"In patients with diabetes mellitus who are undergoing surgery, oral and injectable noninsulin medications should be withheld, replaced with insulin, and resumed at hospital discharge when oral intake and kidney function have normalized."
]
},
{
"type":"keypoint",
"hlId":"b62dcc",
"hvc":true,
"children":[
"Patients with untreated, asymptomatic mild hypothyroidism may proceed to surgery without further testing or treatment."
]
},
{
"type":"keypoint",
"hlId":"629113",
"children":[
"Elective surgery should be deferred in patients with uncontrolled hypo- or hyperthyroidism."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_6",
"title":{
"__html":"Perioperative Management of Kidney Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"e43646",
"children":[
"Perioperative Management of Kidney Disease"
]
},
"children":[
{
"type":"p",
"hlId":"4a603d",
"children":[
"Patients with chronic kidney disease (CKD) are at increased perioperative risk for acute kidney injury (AKI), fluid and electrolyte imbalance, cardiac events, metabolic acidosis, anemia, and bleeding. In all patients with CKD undergoing surgery, it is important to ensure the preoperative stability of kidney function, volume status, and electrolytes. Iodinated contrast dye and other nephrotoxic agents should be avoided in the perioperative period, and hypotension should be minimized to maintain renal perfusion pressure. For patients on hemodialysis, a nephrologist should be consulted for input on perioperative dialysate prescription, hemodialysis timing and heparin management, and adjustment of fluid removal perioperatively."
]
},
{
"type":"p",
"hlId":"cf057e",
"children":[
"Perioperative AKI portends an increased risk for long-term decline in kidney function (including progression to end-stage kidney disease). The two most important means of mitigating risk for AKI are maintenance of renal blood flow and avoidance of further insults to the kidneys. Renal blood flow is maintained by avoiding renal hypoperfusion; effectively managing diuresis and antihypertensive medications; and treating anemia, which may impair peripheral vasodilation. Careful medication review is also warranted to ensure appropriate dosing based on renal clearance."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"c000ce",
"children":[
"The two most important means of mitigating the risk for acute kidney injury in the perioperative period are maintenance of renal blood flow and avoidance of further insults to the kidneys."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_7",
"title":{
"__html":"Perioperative Management of Liver Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"23e392",
"children":[
"Perioperative Management of Liver Disease"
]
},
"children":[
{
"type":"p",
"hlId":"21ed57",
"children":[
"Liver disease increases risk for perioperative infection, encephalopathy, bleeding, fluid retention, and acute kidney and liver decompensation. Patients with chronic liver disease require careful preoperative evaluation and risk stratification using the Model for End-stage Liver Disease (MELD) score and/or Child-Turcotte-Pugh classification. For more information, see ",
{
"type":"cross-reference",
"target":"mk19_a_gi_s6_9",
"children":[
"MKSAP 19 Gastroenterology and Hepatology"
]
},
". Patients with compensated liver disease, including those with a MELD score of less than 8 to 10, are typically able to proceed with surgery with optimal medical management. In patients with intermediate risk, referral to a hepatologist is reasonable before proceeding with surgery. Those with severe liver disease are at often prohibitive risk for perioperative complications and death; patients with a MELD score greater than 15 should be referred for transplant evaluation before surgery if appropriate. Patients with Child-Pugh class C disease or a MELD score greater than 20 are at high risk for death, and all but the most urgent and life-saving surgeries should be avoided until after liver transplantation."
]
},
{
"type":"p",
"hlId":"a3a3fe",
"children":[
"Complications of liver disease should be optimally managed in all patients; however, the American Association for the Study of Liver Diseases recommends against perioperative transjugular intrahepatic portosystemic shunt placement because evidence that the procedure improves outcomes is lacking."
]
},
{
"type":"p",
"hlId":"2c8083",
"children":[
"In general, patients with liver disease should be advised to abstain from alcohol consumption for at least 12 weeks before elective surgery."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_8",
"title":{
"__html":"Perioperative Management of Neurologic Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"6f2d2f",
"children":[
"Perioperative Management of Neurologic Disease"
]
},
"children":[
{
"type":"p",
"hlId":"e1a992",
"children":[
"Patients with neurologic disease are at increased perioperative risk for disease exacerbation and other complications. Antiepileptic medications should be continued uninterrupted."
]
},
{
"type":"p",
"hlId":"153970",
"children":[
"Patients with Parkinson disease are predisposed to perioperative delirium, hallucinations, orthostatic hypotension, and complications related to dysphagia. Patients should maintain their normal treatment regimen. Surgery should be scheduled early in the day to minimize missed doses, and antidopaminergic antiemetics should be avoided. Parkinsonism-hyperpyrexia syndrome is a potentially life-threatening complication resulting from withdrawal of or reduction in the dosage of dopamine agonists; it is characterized by rigidity, fever, altered mental status, and autonomic instability."
]
},
{
"type":"p",
"hlId":"364314",
"children":[
"Perioperative stroke is associated with increased respiratory and cardiac complications and markedly increased mortality. Those at highest risk for perioperative stroke include patients with history of prior stroke or transient ischemic attack (TIA), advanced age, diabetes, heart failure, peripheral vascular disease, CKD, and AKI. Elective noncardiac surgery should probably be delayed for a minimum of 6 months after stroke or TIA owing to unacceptably high risk for recurrent stroke during that time; the risk decreases to a new baseline risk at 9 to 12 months after the event but remains elevated compared with persons who never had a stroke or TIA."
]
},
{
"type":"p",
"hlId":"951288",
"children":[
"Delirium commonly occurs in the postoperative setting, especially in elderly persons. Risk factors and treatment are similar to those for delirium in the general hospital setting. Beyond delirium, patients can also have prolonged cognitive difficulties postoperatively, which may persist for months or longer."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"aaee43",
"children":[
"Patients with Parkinson disease should continue antiparkinson agents through surgery, and surgery should be scheduled for as early in the day as possible to minimize missed doses."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_9",
"title":{
"__html":"Rheumatologic Perioperative Management"
},
"titleNode":{
"type":"section-title",
"hlId":"c5f205",
"children":[
"Rheumatologic Perioperative Management"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s4_9_1",
"title":{
"__html":"Perioperative Management During Disease-Modifying Antirheumatic Drug and Biologic Therapy"
},
"titleNode":{
"type":"section-title",
"hlId":"0153f1",
"children":[
"Perioperative Management During Disease-Modifying Antirheumatic Drug and Biologic Therapy"
]
},
"children":[
{
"type":"p",
"hlId":"cb42ef",
"children":[
"Deferring elective surgery until the rheumatic condition is under optimal control can reduce infection risk and improve outcomes. Traditional oral disease-modifying antirheumatic drugs should be continued through the perioperative period; this will reduce risk for postoperative disease flare with little or no effect on surgical risk. Biologic agents should be withheld for one dosing cycle preoperatively, before the surgery, with surgery performed at the end of the cycle. Janus kinase inhibitors, such as tofacitinib, should be withheld for at least 7 days before surgery. Once the wound shows evidence of healing (typically around 14 days), agents that have been withheld should be resumed at the previously established dose (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_gm_t22",
"wrapId":"14",
"children":[
"Table 22"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"14",
"contentIds":[
"mk19_b_gm_t22"
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_10",
"title":{
"__html":"Perioperative Management of Special Populations"
},
"titleNode":{
"type":"section-title",
"hlId":"701332",
"children":[
"Perioperative Management of Special Populations"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_gm_s4_10_1",
"title":{
"__html":"Geriatric Patients"
},
"titleNode":{
"type":"section-title",
"hlId":"f5c3c5",
"children":[
"Geriatric Patients"
]
},
"children":[
{
"type":"p",
"hlId":"69f929",
"children":[
"As the U.S. population ages, there has been a steep rise in the number of adults older than 65 years undergoing major surgery. It is well established that advanced age, functional dependence, cognitive impairment, and other geriatric syndromes are strong predictors of adverse postoperative outcomes, including pulmonary and cardiac complications, functional decline, and delirium. The American College of Surgeons National Surgical Quality Improvement Program/American Geriatric Society preoperative guidelines focus on best practices to prepare geriatric patients for surgery and mitigate risk. The preoperative evaluation for older adults includes functional, nutritional, and cognitive assessments; medication screening for polypharmacy and high-risk medications; and expanded discussion between clinicians and patients regarding goals and expectations for surgery."
]
},
{
"type":"p",
"hlId":"c9ec5e",
"children":[
"Frailty, defined as decreased physiologic reserves and increased vulnerability to stressors, is present in up to 20% of adults older than 65 years. Frailty can be assessed by several tools (see ",
{
"type":"cross-reference",
"target":"mk19_a_gm_s10_2",
"children":[
"MKSAP 19 General Internal Medicine 1"
]
},
"). Frailty is associated with worse postoperative outcomes and is thus a focus for preoperative intervention. Preoperative multimodal interventions aimed at mitigating frailty risk have been developed. These programs are designed to improve patients' overall health and fitness before surgery and most often include physical therapy, nutritional interventions, and stress-reduction techniques."
]
},
{
"type":"p",
"hlId":"7c06c5",
"children":[
"Malnutrition is a risk factor for perioperative morbidity and may be present in up to 60% of older adults. Preoperative screening for malnutrition with such tools as the Nutritional Risk Screening Tool, which incorporates age, BMI, weight loss, and illness severity (among other factors), is critical to mitigate complications, such as infection and poor wound healing. Loss of 10% to 15% of total body weight during the preceding 6 months, a BMI less than 18.5, and a serum albumin level less than 3.0 g/dL (30 g/L) indicate severe malnutrition and are key predictive factors of poor surgical outcomes. Patients with these features warrant preoperative nutritional interventions with high-protein, high-calorie oral supplementation."
]
},
{
"type":"p",
"hlId":"90ceff",
"children":[
"Finally, before any major surgery, geriatric patients and their families should be educated on delirium risk and prevention, potential for functional and cognitive decline, and possible need for skilled nursing at discharge."
]
},
{
"type":"p",
"hlId":"096903",
"children":[
"For more information, see ",
{
"type":"cross-reference",
"target":"mk19_b_gm_s3_3",
"children":[
"Hospital Medicine Principles"
]
},
"."
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_10_2",
"title":{
"__html":"Pregnant Patients"
},
"titleNode":{
"type":"section-title",
"hlId":"9373f0",
"children":[
"Pregnant Patients"
]
},
"children":[
{
"type":"p",
"hlId":"0a4984",
"children":[
"In women of childbearing age undergoing surgery, a menstrual history should be obtained and pregnancy testing performed if pregnancy is possible."
]
},
{
"type":"p",
"hlId":"a3ae2e",
"children":[
"Although high-quality evidence is lacking and the current body of evidence suggests that surgery does not negatively affect obstetric or maternal outcomes, elective surgery should be delayed until after pregnancy. If surgery cannot be delayed until after delivery, performing surgery during the second trimester is preferred, if possible. Pregnant patients who require surgery should undergo a standard preoperative medical evaluation; additional diagnostic testing is unnecessary unless directed by the obstetrician. Modifications to surgical and anesthetic techniques may be required because of the anatomic and physiologic changes of pregnancy. Close collaboration among the obstetrician, surgeon, anesthesiologist, and internist is essential. Notably, pregnancy is considered a hypercoagulable state, and the ACCP recommends perioperative mechanical or pharmacologic VTE prophylaxis for pregnant patients."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"8dcbf1",
"hvc":true,
"children":[
"Pregnant patients who require surgery should undergo the same preoperative medical evaluation as nonpregnant patients; additional diagnostic testing is unnecessary."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_gm_s4_11",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"American Diabetes Association. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021 Jan;44(Suppl 1):S211-20. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33298426",
"target":"_blank"
},
"children":[
"PMID: 33298426"
]
},
" doi:10.2337/dc21-S015."
]
},
{
"type":"reference",
"children":[
"Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3:3898-944. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31794602",
"target":"_blank"
},
"children":[
"PMID: 31794602"
]
},
" doi:10.1182/bloodadvances.2019000975"
]
},
{
"type":"reference",
"children":[
"Benesch C, Glance LG, Derdeyn CP, et al; American Heart Association Stroke Council; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epidemiology and Prevention. Perioperative neurological evaluation and management to lower the risk of acute stroke in patients undergoing noncardiac, nonneurological surgery: a scientific statement from the American Heart Association/American Stroke Association. Circulation. 2021:CIR0000000000000968. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33827230",
"target":"_blank"
},
"children":[
"PMID: 33827230"
]
},
" doi:10.1161/CIR.0000000000000968"
]
},
{
"type":"reference",
"children":[
"Burton BN, A’Court AM, Brovman EY, et al. Optimizing preoperative anemia to improve patient outcomes. Anesthesiol Clin. 2018;36:701-13. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30390789",
"target":"_blank"
},
"children":[
"PMID: 30390789"
]
},
" doi:10.1016/j.anclin.2018.07.017"
]
},
{
"type":"reference",
"children":[
"Chung F, Memtsoudis SG, Ramachandran SK, et al. Society of anesthesia and sleep medicine guidelines on preoperative screening and assessment of adult patients with obstructive sleep apnea. Anesth Analg. 2016;123:452-73. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27442772",
"target":"_blank"
},
"children":[
"PMID: 27442772"
]
},
" doi:10.1213/ANE.0000000000001416"
]
},
{
"type":"reference",
"children":[
"Cohn SL. Preoperative evaluation for noncardiac surgery. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.acpjournals.org/doi/10.7326/AITC201612060",
"target":"_blank"
},
"children":[
"Ann Intern Med"
]
},
". 2016;165:ITC81-96. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27919097",
"target":"_blank"
},
"children":[
"PMID: 27919097"
]
}
]
},
{
"type":"reference",
"children":[
"Doherty JU, Gluckman TJ, Hucker WJ, et al. 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular Atrial Fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol. 2017;69:871-98. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28081965",
"target":"_blank"
},
"children":[
"PMID: 28081965"
]
},
" doi:10.1016/j.jacc.2016.11.024"
]
},
{
"type":"reference",
"children":[
"Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. 2017;126:547-60. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28121636",
"target":"_blank"
},
"children":[
"PMID: 28121636"
]
},
" doi:10.1097/ALN.0000000000001515"
]
},
{
"type":"reference",
"children":[
"Fleisher LA, Fleischmann KE, Auerbach AD, et al; American College of Cardiology. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e77-137. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25091544",
"target":"_blank"
},
"children":[
"PMID: 25091544"
]
},
" doi:10.1016/j.jacc.2014.07.944"
]
},
{
"type":"reference",
"children":[
"Gialdini G, Nearing K, Bhave PD, et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA. 2014;312:616-22. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25117130",
"target":"_blank"
},
"children":[
"PMID: 25117130"
]
},
" doi:10.1001/jama.2014.9143"
]
},
{
"type":"reference",
"children":[
"Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e227S-77S. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/22315263",
"target":"_blank"
},
"children":[
"PMID: 22315263"
]
},
" doi:10.1378/chest.11-2297"
]
},
{
"type":"reference",
"children":[
"Graham MM, Sessler DI, Parlow JL, et al. Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.acpjournals.org/doi/10.7326/M17-2341",
"target":"_blank"
},
"children":[
"Ann Intern Med"
]
},
". 2018;168:237-44. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29132159",
"target":"_blank"
},
"children":[
"PMID: 29132159"
]
}
]
},
{
"type":"reference",
"children":[
"January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104-32. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30703431",
"target":"_blank"
},
"children":[
"PMID: 30703431"
]
},
" doi:10.1016/j.jacc.2019.01.011"
]
},
{
"type":"reference",
"children":[
"Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;68:1082-115. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27036918",
"target":"_blank"
},
"children":[
"PMID: 27036918"
]
},
" doi:10.1016/j.jacc.2016.03.513"
]
},
{
"type":"reference",
"children":[
"Lin MH, Kamel H, Singer DE, et al. Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke. 2019;50:1364-71. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31043148",
"target":"_blank"
},
"children":[
"PMID: 31043148"
]
},
" doi:10.1161/STROKEAHA.118.023921"
]
},
{
"type":"reference",
"children":[
"Liu MM, Reidy AB, Saatee S, et al. Perioperative steroid management: approaches based on current evidence. Anesthesiology. 2017;127:166-72. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28452806",
"target":"_blank"
},
"children":[
"PMID: 28452806"
]
},
" doi:10.1097/ALN.0000000000001659"
]
},
{
"type":"reference",
"children":[
"Mohanty S, Rosenthal RA, Russell MM, et al. Optimal perioperative management of the geriatric patient: a best practices guideline from the American College of Surgeons NSQIP and the American Geriatrics Society. J Am Coll Surg. 2016;222:930-47. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27049783",
"target":"_blank"
},
"children":[
"PMID: 27049783"
]
},
" doi:10.1016/j.jamcollsurg.2015.12.026"
]
},
{
"type":"reference",
"children":[
"Northup PG, Friedman LS, Kamath PS. AGA clinical practice update on surgical risk assessment and perioperative management in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2019;17:595-606. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30273751",
"target":"_blank"
},
"children":[
"PMID: 30273751"
]
},
" doi:10.1016/j.cgh.2018.09.043"
]
},
{
"type":"reference",
"children":[
"Odor PM, Bampoe S, Gilhooly D, et al. Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis. BMJ. 2020;368:m540. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/32161042",
"target":"_blank"
},
"children":[
"PMID: 32161042"
]
},
" doi:10.1136/bmj.m540"
]
},
{
"type":"reference",
"children":[
"Palace MR. Perioperative management of thyroid dysfunction. Health Serv Insights. 2017;10:1178632916689677. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28469454",
"target":"_blank"
},
"children":[
"PMID: 28469454"
]
},
" doi:10.1177/1178632916689677"
]
},
{
"type":"reference",
"children":[
"Pannucci CJ, Swistun L, MacDonald JK, et al. Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients: a meta-analysis. Ann Surg. 2017;265:1094-103. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28106607",
"target":"_blank"
},
"children":[
"PMID: 28106607"
]
},
" doi:10.1097/SLA.0000000000002126"
]
},
{
"type":"reference",
"children":[
"Pfeifer KJ, Selzer A, Mendez CE, et al. Preoperative management of endocrine, hormonal, and urologic medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement. Mayo Clin Proc. 2021;96:1655-1669. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33714600",
"target":"_blank"
},
"children":[
"PMID: 33714600"
]
},
" doi:10.1016/j.mayocp.2020.10.002"
]
},
{
"type":"reference",
"children":[
"Simha V, Shah P. Perioperative glucose control in patients with diabetes undergoing elective surgery. JAMA. 2019;321:399-400. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30615031",
"target":"_blank"
},
"children":[
"PMID: 30615031"
]
},
" doi:10.1001/jama.2018.20922"
]
},
{
"type":"reference",
"children":[
"Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36:623-50. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28385477",
"target":"_blank"
},
"children":[
"PMID: 28385477"
]
},
" doi:10.1016/j.clnu.2017.02.013"
]
},
{
"type":"reference",
"children":[
"Wijeysundera DN, Beattie WS, Hillis GS, et al; Measurement of Exercise Tolerance before Surgery Study Investigators. Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study. Br J Anaesth. 2020;124:261-70. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31864719",
"target":"_blank"
},
"children":[
"PMID: 31864719"
]
},
" doi:10.1016/j.bja.2019.11.025"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_b_gm_t21":{
"id":"mk19_b_gm_t21",
"number":21,
"bookId":"gm2",
"title":{
"__html":"Selected Indications for Preoperative Laboratory Testing"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"0695a1",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 21. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t21"
}
]
},
"Selected Indications for Preoperative Laboratory Testing"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"675300",
"class":"col hd l",
"children":[
"Laboratory Test",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bf2781",
"class":"col hd l",
"children":[
"Preoperative Indications"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"172a9f",
"class":"cell txt l",
"children":[
"Hemoglobin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f1f553",
"class":"cell txt l",
"children":[
"History of anemia"
]
},
" ",
{
"type":"p",
"hlId":"95e350",
"class":"cell txt l",
"children":[
"Signs/symptoms or examination findings suggestive of anemia"
]
},
" ",
{
"type":"p",
"hlId":"a92e2d",
"class":"cell txt l",
"children":[
"Underlying disease that predisposes to anemia (e.g., kidney disease, myelodysplasia)"
]
},
" ",
{
"type":"p",
"hlId":"db055a",
"class":"cell txt l",
"children":[
"Expected substantial operative blood loss"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"65ed4c",
"class":"cell txt l",
"children":[
"Platelet count"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eec9c2",
"class":"cell txt l",
"children":[
"History of thrombocytopenia or cirrhosis; signs or symptoms of bleeding or liver disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4760b9",
"class":"cell txt l",
"children":[
"Coagulation studies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9ffeb",
"class":"cell txt l",
"children":[
"Warfarin or heparin use"
]
},
" ",
{
"type":"p",
"hlId":"b04d22",
"class":"cell txt l",
"children":[
"History of abnormal bleeding"
]
},
" ",
{
"type":"p",
"hlId":"c6cc37",
"class":"cell txt l",
"children":[
"Medical conditions that predispose to coagulopathy (e.g., liver disease, nutritional disorders, and hemophilia)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"06bcde",
"class":"cell txt l",
"children":[
"Electrolytes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e642b",
"class":"cell txt l",
"children":[
"Diseases that predispose to electrolyte derangements (e.g., kidney disease)"
]
},
" ",
{
"type":"p",
"hlId":"643b7f",
"class":"cell txt l",
"children":[
"Use of medications that can cause electrolyte abnormalities (e.g., diuretics, ACE inhibitors, and ARBs)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e33337",
"class":"cell txt l",
"children":[
"Creatinine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bad2e0",
"class":"cell txt l",
"children":[
"Kidney disease"
]
},
" ",
{
"type":"p",
"hlId":"4614e6",
"class":"cell txt l",
"children":[
"Expected large intraoperative fluid and blood pressure shifts"
]
},
" ",
{
"type":"p",
"hlId":"8ab6c3",
"class":"cell txt l",
"children":[
"Creatinine is also used in preoperative cardiovascular risk calculators and for calculation of the MELD score"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d310ea",
"class":"cell txt l",
"children":[
"Liver chemistry tests (including bilirubin)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"78a32c",
"class":"cell txt l",
"children":[
"Cirrhosis, history of abnormal liver chemistry tests, or signs or symptoms of liver disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"57a6a4",
"class":"cell txt l",
"children":[
"Fasting glucose and hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e01645",
"class":"cell txt l",
"children":[
"Known or suspected diabetes mellitus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"747c2a",
"class":"cell txt l",
"children":[
"Urinalysis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"61a556",
"class":"cell txt l",
"children":[
"Suspected urinary tract infection"
]
},
" ",
{
"type":"p",
"hlId":"39d9d3",
"class":"cell txt l",
"children":[
"Planned urologic procedures"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a661de",
"class":"cell txt l",
"children":[
"Pregnancy test"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d88163",
"class":"cell txt l",
"children":[
"Women of childbearing age"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ARB = angiotensin receptor blocker; MELD = Model for End-stage Liver Disease."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"If the patient is clinically stable and there are no medication changes, tests other than a pregnancy test need not be repeated if performed within 4 months of the procedure."
]
]
},
"mk19_b_gm_t22":{
"id":"mk19_b_gm_t22",
"number":22,
"bookId":"gm2",
"title":{
"__html":"Perioperative Medication Management<sup>a</sup>"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"0a2ea7",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 22. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t22"
}
]
},
"Perioperative Medication Management",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"353bd6",
"class":"col hd l",
"children":[
"Medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2c3767",
"class":"col hd l",
"children":[
"Perioperative Recommendation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cb1eb7",
"class":"col hd l",
"children":[
"Special Considerations"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"5b67a9",
"class":"col hd l",
"children":[
"Cardiovascular Agents"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2854c9",
"class":"cell txt l",
"children":[
"α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
"-Blockers"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"654d9c",
"class":"cell txt l",
"children":[
"Notify surgeon of risk for intraoperative floppy iris syndrome in cataract surgery; temporary cessation may not decrease risk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e3e4b4",
"class":"cell txt l",
"children":[
"α",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-Blockers"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fbd3f5",
"class":"cell txt l",
"children":[
"Do not initiate clonidine for preoperative cardiovascular risk reduction (increases risk for perioperative hypotension)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89aad3",
"class":"cell txt l",
"children":[
"β-Blockers"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ebd362",
"class":"cell txt l",
"children":[
"Consider initiating preoperatively in patients with three or more RCRI risk factors and those with intermediate- or high-risk myocardial ischemia on preoperative stress testing"
]
},
" ",
{
"type":"p",
"hlId":"39d7b5",
"class":"cell txt l",
"children":[
"Begin β-blocker with enough time to assess tolerability; β-blocker should not be started on the day of surgery (≥2 wk before surgery is preferred)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3596ea",
"class":"cell txt l",
"children":[
"Calcium channel blockers"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"734bf3",
"class":"cell txt l",
"children":[
"ACE inhibitors and ARBs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b35d3",
"class":"cell txt l",
"children":[
"Individualize"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a23237",
"class":"cell txt l",
"children":[
"Increases risk for hypotension and AKI and may increase risk for adverse cardiovascular events; typically withhold if prescribed for hypertension (unless blood pressure is poorly controlled); check institutional anesthesiology guidelines; restart as soon as possible postoperatively"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"808737",
"class":"cell txt l",
"children":[
"Diuretics"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6ce69e",
"class":"cell txt l",
"children":[
"Monitor volume status closely if heart failure is present and restart as soon as possible postoperatively"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f73bd",
"class":"cell txt l",
"children":[
"Nitrates"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"295c60",
"class":"cell txt l",
"children":[
"Vasodilators"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"39895a",
"class":"cell txt l",
"children":[
"Statins"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a83e21",
"class":"cell txt l",
"children":[
"Thought to have beneficial pleiotropic effects in addition to lipid-lowering properties"
]
},
" ",
{
"type":"p",
"hlId":"d5be16",
"class":"cell txt l",
"children":[
"Starting preoperatively recommended in patients undergoing vascular surgery and those undergoing elevated-risk noncardiac surgery with long-term indication for statin"
]
},
" ",
{
"type":"p",
"hlId":"ba6ebe",
"class":"cell txt l",
"children":[
"Withhold all other lipid-lowering medications"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f4b13",
"class":"col hd l",
"children":[
"Analgesic Agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d3bf03",
"class":"cell txt l",
"children":[
"NSAIDs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cfe9cc",
"class":"cell txt l",
"children":[
"Withhold for 3-7 days before surgery depending on half-life of NSAID"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"394a71",
"class":"cell txt l",
"children":[
"Opioids"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b35d3",
"class":"cell txt l",
"children":[
"Individualize"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"540924",
"class":"cell txt l",
"children":[
"If surgery is elective, may consider preoperative pain management consultation and opioid taper"
]
},
" ",
{
"type":"p",
"hlId":"307909",
"class":"cell txt l",
"children":[
"Continue in most patients receiving long-term opioid therapy"
]
},
" ",
{
"type":"p",
"hlId":"c1df88",
"class":"cell txt l",
"children":[
"Risk for poorly controlled postoperative pain and respiratory depression"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"07d079",
"class":"cell txt l",
"children":[
"Acetaminophen"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"deb95f",
"class":"col hd l",
"children":[
"Gastrointestinal Agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a60031",
"class":"cell txt l",
"children":[
"Antacid medications (including H",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
"-blockers and proton pump inhibitors)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"69b697",
"class":"cell txt l",
"children":[
"Hyoscyamine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a16ebc",
"class":"cell txt l",
"children":[
"Risk for anticholinergic side effects"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"e014dc",
"class":"col hd l",
"children":[
"Rheumatologic Agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"476428",
"class":"cell txt l",
"children":[
"Hydroxychloroquine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b98cff",
"class":"cell txt l",
"children":[
"Methotrexate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b35d3",
"class":"cell txt l",
"children":[
"Individualize"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f81034",
"class":"cell txt l",
"children":[
"Limited high-quality evidence"
]
},
" ",
{
"type":"p",
"hlId":"47e31a",
"class":"cell txt l",
"children":[
"Probably safe to continue in most situations; withhold if significant concern for infection or history of septic complications; dose adjust in cases of kidney injury"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85bc4f",
"class":"cell txt l",
"children":[
"Biologics"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e2f771",
"class":"cell txt l",
"children":[
"Balance risks for infection and postoperative disease flare"
]
},
" ",
{
"type":"p",
"hlId":"b2638f",
"class":"cell txt l",
"children":[
"Reasonable to schedule surgery at end of dosing cycle, withholding dose at time of surgery and not resuming for ≥2 wk after surgery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_4-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ad08e",
"class":"cell txt l",
"children":[
"Tofacitinib"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"613a10",
"class":"cell txt l",
"children":[
"Hold for ≥7 d before elective total hip or total knee replacement and do not resume for ≥2 wk after surgery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"1f989f",
"class":"col hd l",
"children":[
"Urologic Agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a3674d",
"class":"cell txt l",
"children":[
"α-1 Adrenergic antagonists"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"654d9c",
"class":"cell txt l",
"children":[
"Notify surgeon of risk for intraoperative floppy iris syndrome in cataract surgery; temporary cessation may not decrease risk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f4ef4b",
"class":"cell txt l",
"children":[
"5α-Reductase inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b57816",
"class":"cell txt l",
"children":[
"Anticholinergic bladder dysfunction medications"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"499402",
"class":"cell txt l",
"children":[
"Withhold on day of surgery; high potential for side effects in older patients"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f30b92",
"class":"cell txt l",
"children":[
"Mirabegron"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"95ae32",
"class":"cell txt l",
"children":[
"Withhold on day of surgery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccba46",
"class":"cell txt l",
"children":[
"PDE-5 inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a3c90a",
"class":"cell txt l",
"children":[
"Withhold for 3 days prior to surgery (unless used for treatment of pulmonary hypertension)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_5-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"32f975",
"class":"cell txt l",
"children":[
"Androgen deprivation therapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"619cbb",
"class":"cell txt l",
"children":[
"Medications used for the treatment of prostate cancer"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"6dc805",
"class":"col hd l",
"children":[
"Psychiatric Agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0c7b03",
"class":"cell txt l",
"children":[
"Selective serotonin reuptake inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"266fee",
"class":"cell txt l",
"children":[
"Usually continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"15d170",
"class":"cell txt l",
"children":[
"May increase risk for bleeding, especially in conjunction with antiplatelet agents; risk for withdrawal symptoms with abrupt cessation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"521c0d",
"class":"cell txt l",
"children":[
"Benzodiazepines"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b77c44",
"class":"cell txt l",
"children":[
"Risk for withdrawal with abrupt cessation; monitor for respiratory depression"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_6-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"de15a9",
"class":"cell txt l",
"children":[
"Antipsychotics"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0bfb8",
"class":"cell txt l",
"children":[
"Continue"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"abe2f0",
"class":"cell txt l",
"children":[
"Potential for QT prolongation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"56c169",
"class":"col hd l",
"children":[
"Supplements"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"feda77",
"class":"cell txt l",
"children":[
"Herbal preparations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"909905",
"class":"cell txt l",
"children":[
"Withhold 1-2 wk preoperatively"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_7-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1d866f",
"class":"cell txt l",
"children":[
"Vitamins and supplements"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4ae3d",
"class":"cell txt l",
"children":[
"Withhold"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26aeab",
"class":"cell txt l",
"children":[
"—"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"AKI = acute kidney injury; ARB = angiotensin receptor blocker; PDE-5 = phosphodiesterase-5; RCRI = Revised Cardiac Risk Index."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Perioperative management of antiplatelet agents, anticoagulants, antiepileptic drugs, glucocorticoids, and diabetes medications is discussed later in this chapter."
],
[
"Information from Fleisher LA, Fleischmann KE, Auerbach AD, et al; American College of Cardiology. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64:e77-137. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25091544",
"target":"_blank"
},
"children":[
"PMID: 25091544"
]
},
" doi:10.1016/j.jacc.2014.07.944 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Devereaux PJ, Sessler DI, Leslie K, et al; POISE-2 Investigators. Clonidine in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1504-13. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/24679061",
"target":"_blank"
},
"children":[
"PMID: 24679061"
]
},
" doi:10.1056/NEJMoa1401106 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Goodman SM, Springer B, Guyatt G, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol. 2017;69:1538-51. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28620948",
"target":"_blank"
},
"children":[
"PMID: 28620948"
]
},
" doi:10.1002/art.40149 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Pfeifer KJ, Selzer A, Mendez CE, et al. Preoperative management of endocrine, hormonal, and urologic medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement. Mayo Clin Proc. 2021;96:1655-1669. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33714600",
"target":"_blank"
},
"children":[
"PMID: 33714600"
]
},
" doi:10.1016/j.mayocp.2020.10.002"
]
]
},
"mk19_b_gm_t23":{
"id":"mk19_b_gm_t23",
"number":23,
"bookId":"gm2",
"title":{
"__html":"Revised Cardiac Risk Index and Predicted Rate of Major Cardiac Complications Perioperatively"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"304e71",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 23. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t23"
}
]
},
"Revised Cardiac Risk Index and Predicted Rate of Major Cardiac Complications Perioperatively"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e4b64",
"class":"col hd l",
"children":[
"Risk Factor (1 point for each)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"17b5a9",
"class":"cell txt l",
"children":[
"High-risk surgery (intrathoracic, intraperitoneal, suprainguinal vascular)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"5fd3c1",
"class":"cell txt l",
"children":[
"Ischemic heart disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"77e544",
"class":"cell txt l",
"children":[
"Heart failure (compensated)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"825b5a",
"class":"cell txt l",
"children":[
"Diabetes mellitus (requiring insulin)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"9fdb23",
"class":"cell txt l",
"children":[
"Cerebrovascular disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"afad17",
"class":"cell txt l",
"children":[
"Chronic kidney disease (serum creatinine >2.0 mg/dL [176.8 µmol/L])",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"442d73",
"class":"col hd l",
"children":[
"Number of Points"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"785bef",
"class":"col hd l",
"children":[
"Risk for Major Cardiac Complications",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cfcd20",
"class":"cell txt l",
"children":[
"0"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f92ab3",
"class":"cell txt l",
"children":[
"0.4%-0.5%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c4ca42",
"class":"cell txt l",
"children":[
"1"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"59fbb0",
"class":"cell txt l",
"children":[
"1.0%-2.6%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c81e72",
"class":"cell txt l",
"children":[
"2"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e94d73",
"class":"cell txt l",
"children":[
"2.4%-7.2%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b691e",
"class":"cell txt l",
"children":[
"≥3"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3fa3fc",
"class":"cell txt l",
"children":[
"5.4%-14.4%"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Estimated glomerular filtration rate <30 mL/min/1.73 m",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
" is also shown to predict cardiovascular risk."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Defined as cardiac death, nonfatal myocardial infarction, and nonfatal cardiac arrest (original validation also included pulmonary edema and complete heart block). Percentages represent incidence measured during inpatient timeframe. Validations using 30-day time frames have demonstrated significantly higher rates, even among patients with a score of 0."
],
[
"Data from Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-9. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/10477528",
"target":"_blank"
},
"children":[
"PMID: 10477528"
]
},
" doi:10.1161/01.cir.100.10.1043 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Davis C, Tait G, Carroll J, et al. The Revised Cardiac Risk Index in the new millennium: a single-centre prospective cohort re-evaluation of the original variables in 9,519 consecutive elective surgical patients. Can J Anaesth. 2013;60:855-63. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/23813289",
"target":"_blank"
},
"children":[
"PMID: 23813289"
]
},
" doi:10.1007/s12630-013-9988-5"
]
]
},
"mk19_b_gm_t24":{
"id":"mk19_b_gm_t24",
"number":24,
"bookId":"gm2",
"title":{
"__html":"Comparison of Tools for Estimating Major Adverse Cardiovascular Event Risk"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"dec0df",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 24. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t24"
}
]
},
"Comparison of Tools for Estimating Major Adverse Cardiovascular Event Risk"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"col hd l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"c1e717",
"class":"col hd c",
"children":[
"ASC NSQIP Calculators"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7c3745",
"class":"col hd l",
"children":[
"Characteristic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"463c49",
"class":"col hd l",
"children":[
"RCRI"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d8734",
"class":"col hd l",
"children":[
"MICA Risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc03ac",
"class":"col hd l",
"children":[
"Surgical Risk"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f228f1",
"class":"cell txt l",
"children":[
"External validation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"96c8cb",
"class":"cell txt l",
"children":[
"Multiple studies"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"30fc6b",
"class":"cell txt l",
"children":[
"Minimal"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"30fc6b",
"class":"cell txt l",
"children":[
"Minimal"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c46499",
"class":"cell txt l",
"children":[
"Surgical population"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e930f",
"class":"cell txt l",
"children":[
"Inpatient (hospitalization for 2 d) for most validations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"427be0",
"class":"cell txt l",
"children":[
"All, except for some low-risk procedures"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"427be0",
"class":"cell txt l",
"children":[
"All, except for some low-risk procedures"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"569c25",
"class":"cell txt l",
"children":[
"Measured cardiovascular outcomes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"30e642",
"class":"cell txt l",
"children":[
"MI, cardiac death/ventricular fibrillation, pulmonary edema, complete heart block"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2b312e",
"class":"cell txt l",
"children":[
"MICA"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a44246",
"class":"cell txt l",
"children":[
"MI and cardiac death"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e04857",
"class":"cell txt l",
"children":[
"Outcome measurement time frame"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e9cff3",
"class":"cell txt l",
"children":[
"Inpatient only for most validations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2af4b",
"class":"cell txt l",
"children":[
"30 d postoperatively"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2af4b",
"class":"cell txt l",
"children":[
"30 d postoperatively"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e646e1",
"class":"cell txt l",
"children":[
"Limitations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7da18c",
"class":"cell txt l",
"children":[
"Tendency to overestimate risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d794dc",
"class":"cell txt l",
"children":[
"Surgical types combined into broad categories that could lead to inaccurate assessment of risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7da18c",
"class":"cell txt l",
"children":[
"Tendency to overestimate risk"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ACS NSQIP = American Cancer Society National Surgical Quality Improvement Program; MI = myocardial infarction; MICA = myocardial infarction and cardiac arrest; RCRI = Revised Cardiac Risk Index."
]
]
},
"mk19_b_gm_t25":{
"id":"mk19_b_gm_t25",
"number":25,
"bookId":"gm2",
"title":{
"__html":"Duke Activity Status Index (DASI) Score Questionnaire"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"6b0001",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 25. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t25"
}
]
},
"Duke Activity Status Index (DASI) Score Questionnaire"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4b2e4c",
"class":"col hd l",
"children":[
"Questionnaire Item"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3f9546",
"class":"col hd l",
"children":[
"Points (each “Yes” answer)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dc0a2a",
"class":"cell txt l",
"children":[
"1. Can you take care of yourself (e.g., eat, dress, bathe, or use the toilet)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f11c03",
"class":"cell txt l",
"children":[
"2.75"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c061b8",
"class":"cell txt l",
"children":[
"2. Can you walk indoors (e.g., throughout the rooms of your house)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f7dee5",
"class":"cell txt l",
"children":[
"1.75"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc19b0",
"class":"cell txt l",
"children":[
"3. Can you walk one to two blocks on level ground?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f11c03",
"class":"cell txt l",
"children":[
"2.75"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc00d9",
"class":"cell txt l",
"children":[
"4. Can you climb a flight of stairs or walk up a hill?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f224e5",
"class":"cell txt l",
"children":[
"5.50"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26db0d",
"class":"cell txt l",
"children":[
"5. Can you run a short distance?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0ed90",
"class":"cell txt l",
"children":[
"8.00"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"96c41b",
"class":"cell txt l",
"children":[
"6. Can you do ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"light"
]
},
" work around the house (e.g., dusting, washing dishes)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b4a699",
"class":"cell txt l",
"children":[
"2.70"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"956e87",
"class":"cell txt l",
"children":[
"7. Can you do ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"moderate"
]
},
" work around the house (e.g., vacuuming, sweeping floors, or carrying groceries)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a61d5",
"class":"cell txt l",
"children":[
"3.50"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e28c05",
"class":"cell txt l",
"children":[
"8. Can you do ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"heavy"
]
},
" work around the house (e.g., scrubbing floors, lifting or moving heavy furniture)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a0ed90",
"class":"cell txt l",
"children":[
"8.00"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a8c8dd",
"class":"cell txt l",
"children":[
"9. Can you do yard work (e.g., raking leaves, weeding, pushing a power lawnmower)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"beaddd",
"class":"cell txt l",
"children":[
"4.50"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3a886c",
"class":"cell txt l",
"children":[
"10. Can you have sexual relations?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"00d034",
"class":"cell txt l",
"children":[
"5.25"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"49364e",
"class":"cell txt l",
"children":[
"11. Can you participate in ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"moderate"
]
},
" recreational activities (e.g., golf, bowling, dancing, doubles tennis, or throwing a ball)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2f68ad",
"class":"cell txt l",
"children":[
"6.00"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-12 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4b8377",
"class":"cell txt l",
"children":[
"12. Can you participate in ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"strenuous"
]
},
" sports (e.g., swimming, singles tennis, football, basketball, or skiing)?"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4ad131",
"class":"cell txt l",
"children":[
"7.50"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"In Wijeysundera and colleagues 2020, a DASI score of 34 (equivalent to ~5 METs in the study population) was the cutoff below which patients experienced elevated risk for 30-day mortality and myocardial infarction."
],
[
"Reproduced with permission from Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651-4. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/2782256",
"target":"_blank"
},
"children":[
"PMID: 2782256"
]
},
" doi:10.1016/&#8232;0002-9149(89)90496-7"
],
[
"Wijeysundera DN, Beattie WS, Hillis GS, et al; Measurement of Exercise Tolerance before Surgery Study Investigators. Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study. Br J Anaesth. 2020;124:261-70. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31864719",
"target":"_blank"
},
"children":[
"PMID: 31864719"
]
},
" doi:10.1016/j.bja.2019.11.025"
]
]
},
"mk19_b_gm_t26":{
"id":"mk19_b_gm_t26",
"number":26,
"bookId":"gm2",
"title":{
"__html":"Pulmonary Risk Factors"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"492ab6",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 26. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t26"
}
]
},
"Pulmonary Risk Factors"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"56a2f3",
"class":"col hd l",
"children":[
"Patient-Related Risk Factors"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d8d2d",
"class":"cell txt l",
"children":[
"Age"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b576de",
"class":"cell txt l",
"children":[
"COPD"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"022af2",
"class":"cell txt l",
"children":[
"Cigarette use"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e63d41",
"class":"cell txt l",
"children":[
"ASA class ≥2",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0940ec",
"class":"cell txt l",
"children":[
"Functional dependence"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0bf538",
"class":"cell txt l",
"children":[
"Obstructive sleep apnea"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b78c6",
"class":"cell txt l",
"children":[
"Heart failure"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ddcd5",
"class":"cell txt l",
"children":[
"Serum albumin level <3 g/dL (30 g/L)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"99f336",
"class":"col hd l",
"children":[
"Procedure-Related Risk Factors"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ba3394",
"class":"cell txt l",
"children":[
"Surgery in close proximity to the airway or diaphragm (aortic, thoracic, abdominal)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7c2a3f",
"class":"cell txt l",
"children":[
"Head and neck surgery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4a6946",
"class":"cell txt l",
"children":[
"Neurosurgery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"596735",
"class":"cell txt l",
"children":[
"Major vascular surgery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c0203",
"class":"cell txt l",
"children":[
"Procedure duration >2 h"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fed3b0",
"class":"cell txt l",
"children":[
"Emergency surgery"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ASA = American Society of Anesthesiologists."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"ASA classes are as follows: class 1, normal healthy patient; class 2, patient with mild systemic disease; class 3, patient with severe systemic disease; class 4, patient with systemic disease that is a constant threat to life; and class 5, moribund patient who is not expected to survive for 24 hours with or without operation."
],
[
"Adapted with permission from Smetana GW, Lawrence VA, Cornell JE; American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.acpjournals.org/doi/10.7326/0003-4819-144-8-200604180-00009",
"target":"_blank"
},
"children":[
"Ann Intern Med"
]
},
". 2006;144:584, 587. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/16618956",
"target":"_blank"
},
"children":[
"PMID: 16618956"
]
}
],
[
"Copyright 2006, American College of Physicians."
]
]
},
"mk19_b_gm_t27":{
"id":"mk19_b_gm_t27",
"number":27,
"bookId":"gm2",
"title":{
"__html":"STOP-BANG Obstructive Sleep Apnea Screening Tool"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"fbc4f1",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 27. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t27"
}
]
},
"STOP-BANG Obstructive Sleep Apnea Screening Tool"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"7b2cb2",
"class":"col hd l",
"children":[
"Survey Items (1 point for each)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"c3d338",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"S"
]
},
"noring"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"407548",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"T"
]
},
"iredness or sleepiness during the day"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"ba20b8",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"O"
]
},
"bserved apnea during sleep"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"d5ffff",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"P"
]
},
"ressure, high blood"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"80fb71",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"B"
]
},
"MI >35"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"9bcd94",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"A"
]
},
"ge >50 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"4b8381",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"N"
]
},
"eck circumference >40 cm (15.7 in)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"32b487",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"G"
]
},
"ender = male"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"58334b",
"class":"col hd l",
"children":[
"STOP-BANG Score"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae0180",
"class":"col hd l",
"children":[
"Risk Correlation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dfbffa",
"class":"cell txt l",
"children":[
"0-2"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e299ae",
"class":"cell txt l",
"children":[
"Low risk for OSA"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b691e",
"class":"cell txt l",
"children":[
"≥3"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b565a",
"class":"cell txt l",
"children":[
"Increased risk for OSA"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9c30cf",
"class":"cell txt l",
"children":[
"≥5"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"89917e",
"class":"cell txt l",
"children":[
"Increased risk for moderate to severe OSA"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"OSA = obstructive sleep apnea."
],
[
"Adapted with permission from Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108:812-21. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/18431116",
"target":"_blank"
},
"children":[
"PMID: 18431116"
]
},
" doi:10.1097/ALN.0b013e31816d83e4 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Chung F, Subramanyam R, Liao P, et al. High STOP-Bang score indicates a high probability of obstructive sleep apnoea. Br J Anaesth. 2012;108:768-75. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/22401881",
"target":"_blank"
},
"children":[
"PMID: 22401881"
]
},
" doi:10.1093/bja/aes022"
]
]
},
"mk19_b_gm_t28":{
"id":"mk19_b_gm_t28",
"number":28,
"bookId":"gm2",
"title":{
"__html":"Postoperative Venous Thromboembolism Prophylaxis Recommendations for Common Noncardiothoracic Surgeries"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"722504",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 28. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t28"
}
]
},
"Postoperative Venous Thromboembolism Prophylaxis Recommendations for Common Noncardiothoracic Surgeries"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"992f94",
"class":"col hd c",
"children":[
"Surgery and Risks"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a04ec2",
"class":"col hd l",
"children":[
"Recommended Prophylaxis",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4f2b81",
"class":"cell txt l",
"children":[
"General, abdominal-pelvic, urologic, plastic, vascular"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6e2ebc",
"class":"cell txt l",
"children":[
"Caprini",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
" score 0"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca0310",
"class":"cell txt l",
"children":[
"Early ambulation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac6f54",
"class":"cell txt l",
"children":[
"Caprini score 1-2"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"985712",
"class":"cell txt l",
"children":[
"Low VTE risk",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
" (NA)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"632a23",
"class":"cell txt l",
"children":[
"IPC only"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"792f70",
"class":"cell txt l",
"children":[
"Caprini score 3-4"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23a21d",
"class":"cell txt l",
"children":[
"Average bleeding risk; moderate VTE risk (0.7%)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"067167",
"class":"cell txt l",
"children":[
"LMWH, LDUH, or IPC"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64da97",
"class":"cell txt l",
"children":[
"High bleeding risk",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"632a23",
"class":"cell txt l",
"children":[
"IPC only"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"22d1e2",
"class":"cell txt l",
"children":[
"Caprini score 5-6"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5ac010",
"class":"cell txt l",
"children":[
"Average bleeding risk; high VTE risk (1.8%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2690e2",
"class":"cell txt l",
"children":[
"LMWH or LDUH (+ IPC)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8f2eb9",
"class":"cell txt l",
"children":[
"Caprini score 7-8"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d9fdd",
"class":"cell txt l",
"children":[
"High bleeding risk",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
"; high VTE risk (4%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"632a23",
"class":"cell txt l",
"children":[
"IPC only"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"35aa94",
"class":"cell txt l",
"children":[
"Caprini score >8"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"29f5b0",
"class":"cell txt l",
"children":[
"High VTE risk (10.7%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"289141",
"class":"cell txt l",
"children":[
"Orthopedic"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a65c69",
"class":"cell txt l",
"children":[
"Hip or knee arthroplasty"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dcf633",
"class":"cell txt l",
"children":[
"IPC during hospital stay ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" aspirin or DOAC for 21-35 days; LMWH over warfarin or LDUH as secondary options; if high bleeding risk, IPC alone during hospital stay"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4215df",
"class":"cell txt l",
"children":[
"Hip fracture repair"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"66bb5c",
"class":"cell txt l",
"children":[
"IPC during hospital stay ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" LMWH or LDUH for 21-35 days; fondaparinux, adjusted-dose VKA, aspirin secondary options; if high bleeding risk, IPC alone during hospital stay"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8dffb3",
"class":"cell txt l",
"children":[
"Isolated lower leg fracture repairs"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6adf97",
"class":"cell txt l",
"children":[
"None"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"380535",
"class":"cell txt l",
"children":[
"Knee arthroscopy with no previous VTE"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca0310",
"class":"cell txt l",
"children":[
"Early ambulation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fcffec",
"class":"cell txt l",
"children":[
"Spine (elective)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e99ef9",
"class":"cell txt l",
"children":[
"Average VTE risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c8660c",
"class":"cell txt l",
"children":[
"IPC"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f12870",
"class":"cell txt l",
"children":[
"High VTE risk (e.g., malignancy, anterior-posterior approach)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"218530",
"class":"cell txt l",
"children":[
"IPC + LMWH (when bleeding risk sufficiently low)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"11f310",
"class":"cell txt l",
"children":[
"Major trauma"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e99ef9",
"class":"cell txt l",
"children":[
"Average VTE risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"067167",
"class":"cell txt l",
"children":[
"LMWH, LDUH, or IPC"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2c471",
"class":"cell txt l",
"children":[
"High VTE risk (e.g., spinal cord or brain injury)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2690e2",
"class":"cell txt l",
"children":[
"LMWH or LDUH (+ IPC)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ec64a4",
"class":"cell txt l",
"children":[
"High bleeding risk",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c8660c",
"class":"cell txt l",
"children":[
"IPC"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8fb816",
"class":"cell txt l",
"children":[
"Intracranial"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e99ef9",
"class":"cell txt l",
"children":[
"Average VTE risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c8660c",
"class":"cell txt l",
"children":[
"IPC"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d540ad",
"class":"cell txt l",
"children":[
"High VTE risk (e.g., malignancy)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2690e2",
"class":"cell txt l",
"children":[
"LMWH or LDUH (+ IPC)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"294b8c",
"class":"cell txt l",
"children":[
"Cancer surgery"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"68f6ca",
"class":"cell txt l",
"children":[
"High risk (major open or laparoscopic abdominal or pelvic surgery and restricted mobility, obesity, history of VTE, or additional risk factors)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8b3b36",
"class":"cell txt l",
"children":[
"UFH or LMWH up to 4 wk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b8622",
"class":"cell txt l",
"children":[
"Not identified as high risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"47419c",
"class":"cell txt l",
"children":[
"UFH or LMWH for =7-10 d"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"DOAC = direct oral anticoagulant; IPC = intermittent pneumatic compression; LDUH = low-dose unfractionated heparin; LMWH = low-molecular-weight heparin; NA = not applicable; UFH = unfractionated heparin; VKA = vitamin K antagonist; VTE = venous thromboembolism."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Duration is for postoperative hospitalization unless noted otherwise."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"See the Caprini Score for Venous Thromboembolism: ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.mdcalc.com/caprini-score-venous-thromboembolism-2005",
"target":"_blank"
},
"children":[
"www.mdcalc.com/caprini-score-venous-thromboembolism-2005"
]
},
"."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Caprini and colleagues' 2017 meta-analysis of 14,700 patients in 11 studies showed that Caprini scores >7 benefited from VTE chemoprophylaxis-but it was less clear for intermediate risk (Caprini 3-6). The American Society of Hematology does not specifically suggest using the Caprini risk tool for determining high risk for VTE but does recommend LMWH or LDUH (+IPC) for patients with acceptable bleeding risk."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
"Risk factors suggesting high bleeding risk: concurrent antithrombotic therapy (e.g., aspirin for cardiac disease), known or suspected bleeding disorder, active bleeding, liver or kidney disease, and sepsis."
],
[
"Recommendations from Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e227S-277S. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/22315263",
"target":"_blank"
},
"children":[
"PMID: 22315263"
]
},
" doi:10.1378/chest.11-2297; ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e278S-325S. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/22315265",
"target":"_blank"
},
"children":[
"PMID: 22315265"
]
},
" doi:10.1378/chest.11-2404; ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3:3898-944. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31794602",
"target":"_blank"
},
"children":[
"PMID: 31794602"
]
},
" doi:10.1182/bloodadvances.2019000975"
],
[
"Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update [published online ahead of print, 2019 Aug 5]. J Clin Oncol. 2019;JCO1901461. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31381464",
"target":"_blank"
},
"children":[
"PMID: 31381464"
]
},
" doi:10.1200/JCO.19.0146"
],
[
"Pannucci CJ, Swistun L, MacDonald JK, et al. Individualized venous thromboembolism risk stratification using the 2005 caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients: a meta-analysis. Ann Surg. 2017;265:1094-103. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28106607",
"target":"_blank"
},
"children":[
"PMID: 28106607"
]
},
" doi:10.1097/SLA.0000000000002126"
]
]
},
"mk19_b_gm_t29":{
"id":"mk19_b_gm_t29",
"number":29,
"bookId":"gm2",
"title":{
"__html":"Recommendations for Perioperative Bridging in Patients With a Prosthetic Heart Valve"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"c35dcd",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 29. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t29"
}
]
},
"Recommendations for Perioperative Bridging in Patients With a Prosthetic Heart Valve"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd88de",
"class":"col hd l",
"children":[
"Risk for Thromboembolism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c623fc",
"class":"col hd l",
"children":[
"Patient History"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8191d7",
"class":"col hd l",
"children":[
"Bridging Anticoagulation Recommendation"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9f8d6d",
"class":"cell txt l",
"children":[
"High (annual risk >10%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d76aec",
"class":"cell txt l",
"children":[
"Any mitral valve prosthesis"
]
},
" ",
{
"type":"p",
"hlId":"589ce9",
"class":"cell txt l",
"children":[
"Any caged-ball or tilting disc aortic valve prosthesis"
]
},
" ",
{
"type":"p",
"hlId":"c36a69",
"class":"cell txt l",
"children":[
"Recent (within 6 mo) stroke or TIA"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eac98d",
"class":"cell txt l",
"children":[
"Bridging"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67484d",
"class":"cell txt l",
"children":[
"Moderate (annual risk of 5%-10%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ae32c0",
"class":"cell txt l",
"children":[
"Bileaflet aortic valve prosthesis and one or more of the following risk factors: atrial fibrillation, previous stroke or TIA, hypertension, diabetes mellitus, heart failure, age >75 y"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0e8f99",
"class":"cell txt l",
"children":[
"Bridging unless procedure is associated with a high bleeding risk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5f4227",
"class":"cell txt l",
"children":[
"Low (annual risk <5%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d7d31e",
"class":"cell txt l",
"children":[
"Bileaflet aortic valve prosthesis without atrial fibrillation and no other risk factors for stroke"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16c768",
"class":"cell txt l",
"children":[
"No bridging"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"TIA = transient ischemic attack."
],
[
"Recommendations from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e326S-350S. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/22315266",
"target":"_blank"
},
"children":[
"PMID: 22315266"
]
},
" doi:10.1378/chest.11-2298 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;70:252-29. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28315732",
"target":"_blank"
},
"children":[
"PMID: 28315732"
]
},
" doi:10.1016/j.jacc.2017.03.011"
]
]
},
"mk19_b_gm_t30":{
"id":"mk19_b_gm_t30",
"number":30,
"bookId":"gm2",
"title":{
"__html":"Recommendations for Perioperative Bridging in Patients With Venous Thromboembolism Requiring Interruption of Vitamin K Antagonist Therapy"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"7c62f3",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 30. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t30"
}
]
},
"Recommendations for Perioperative Bridging in Patients With Venous Thromboembolism Requiring Interruption of Vitamin K Antagonist Therapy"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cd88de",
"class":"col hd l",
"children":[
"Risk for Thromboembolism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c623fc",
"class":"col hd l",
"children":[
"Patient History"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8191d7",
"class":"col hd l",
"children":[
"Bridging Anticoagulation Recommendation"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9f8d6d",
"class":"cell txt l",
"children":[
"High (annual risk >10%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"402f17",
"class":"cell txt l",
"children":[
"Recent (within 3 mo) VTE"
]
},
" ",
{
"type":"p",
"hlId":"cfe38f",
"class":"cell txt l",
"children":[
"Severe thrombophilia (e.g., deficiency of protein C, protein S, or antithrombin; antiphospholipid antibodies; multiple thrombophilic abnormalities)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eac98d",
"class":"cell txt l",
"children":[
"Bridging"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67484d",
"class":"cell txt l",
"children":[
"Moderate (annual risk of 5%-10%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7694b3",
"class":"cell txt l",
"children":[
"VTE within the past 3-12 mo"
]
},
" ",
{
"type":"p",
"hlId":"94c12d",
"class":"cell txt l",
"children":[
"Nonsevere thrombophilia (e.g., heterozygous factor V Leiden or prothrombin gene mutation)"
]
},
" ",
{
"type":"p",
"hlId":"49e913",
"class":"cell txt l",
"children":[
"Recurrent VTE"
]
},
" ",
{
"type":"p",
"hlId":"48b8bf",
"class":"cell txt l",
"children":[
"Active cancer (treated within 6 mo or palliative)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16c768",
"class":"cell txt l",
"children":[
"No bridging"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5f4227",
"class":"cell txt l",
"children":[
"Low (annual risk <5%)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"86f430",
"class":"cell txt l",
"children":[
"VTE >12 mo ago and no other risk factors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16c768",
"class":"cell txt l",
"children":[
"No bridging"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"VTE = venous thromboembolism."
],
[
"Recommendations from Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2:3257-91. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30482765",
"target":"_blank"
},
"children":[
"PMID: 30482765"
]
},
" doi:10.1182/bloodadvances.2018024893 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e227S-e277S. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/22315263",
"target":"_blank"
},
"children":[
"PMID: 22315263"
]
},
" doi:10.1378/chest.11-2297"
]
]
},
"mk19_b_gm_t31":{
"id":"mk19_b_gm_t31",
"number":31,
"bookId":"gm2",
"title":{
"__html":"Stress Dosing Strategies in Patients at Risk for Adrenal Insufficiency"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"9f0c23",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 31. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t31"
}
]
},
"Stress Dosing Strategies in Patients at Risk for Adrenal Insufficiency"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9b03a0",
"class":"col hd l",
"children":[
"Patient Risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dee5e2",
"class":"col hd l",
"children":[
"Patient Characteristics"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fe4dbc",
"class":"col hd l",
"children":[
"Management"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"741fee",
"class":"cell txt l",
"children":[
"High risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3540c5",
"class":"cell txt l",
"children":[
"Established primary or secondary adrenal insufficiency"
]
},
" ",
{
"type":"p",
"hlId":"aefc86",
"class":"cell txt l",
"children":[
"Cushingoid features"
]
},
" ",
{
"type":"p",
"hlId":"20dc17",
"class":"cell txt l",
"children":[
"Current equivalent of >20 mg/d prednisone for >3 wk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c66632",
"class":"cell txt l",
"children":[
"Stress dosing"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ff10b",
"class":"cell txt l",
"children":[
"Moderate or possible risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"598a2e",
"class":"cell txt l",
"children":[
"Past use equivalent of >20 mg/d prednisone for >3 wk during past year"
]
},
" ",
{
"type":"p",
"hlId":"aa3ff2",
"class":"cell txt l",
"children":[
"Current or past equivalent of >5-20 mg/d prednisone for >3 wk during past year"
]
},
" ",
{
"type":"p",
"hlId":"dad1fe",
"class":"cell txt l",
"children":[
"Chronic high-dose inhaled or topical glucocorticoid therapy"
]
},
" ",
{
"type":"p",
"hlId":"2661e2",
"class":"cell txt l",
"children":[
"Recent intra-articular glucocorticoid therapy (≥3 injectable glucocorticoid treatments within 3 mo before surgery)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"999abe",
"class":"cell txt l",
"children":[
"Stress dosing or preoperative adrenal axis testing may be indicated"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5f59a",
"class":"cell txt l",
"children":[
"Low risk"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eca601",
"class":"cell txt l",
"children":[
"Equivalent of <5 mg/d of prednisone for any duration"
]
},
" ",
{
"type":"p",
"hlId":"7ea3c2",
"class":"cell txt l",
"children":[
"Any dose steroid for <3 wk"
]
},
" ",
{
"type":"p",
"hlId":"b25319",
"class":"cell txt l",
"children":[
"Low-dose inhaled or topical glucocorticoid therapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f773b3",
"class":"cell txt l",
"children":[
"No stress dosing"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"Adapted from Liu MM, Reidy AB, Saatee S, et al. Perioperative steroid management: approaches based on current evidence. Anesthesiology. 2017;127:166-72. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28452806",
"target":"_blank"
},
"children":[
"PMID: 28452806"
]
},
" doi:10.1097/ALN.0000000000001659 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020;75:654-63. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/32017012",
"target":"_blank"
},
"children":[
"PMID: 32017012"
]
},
" doi:10.1111/anae.14963"
]
]
}
}
}